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ABSTRACT 
The human body’s intracranial pressure (ICP) is a critical component in 
sustaining healthy blood flow to the brain while allowing adequate volume for 
brain tissue within the rigid structures of the cranium.  Disruptions in the body’s 
autoregulation of intracranial pressure are often caused by hemorrhage, tumors, 
edema, or excess cerebral spinal fluid resulting in treatments that are estimated 
to globally cost up to approximately five billion dollars annually.  A critical element 
in the contemporary management of acute head injury, intracranial hemorrhage, 
stroke, or other conditions resulting in intracranial hypertension, is the real-time 
monitoring of ICP.  Currently, such mainstream clinical monitoring can only take 
place short-term within an acute care hospital.  The monitoring is prone to 
measurement drift and is comprised of externally tethered pressure sensors that 
are temporarily implanted into the brain, thus carrying a significant risk of 
infection.  To date, reliable, low drift, completely internalized, long-term ICP 
monitoring devices remain elusive.  The successful development of such a 
device would not only be safer and more reliable in the short-term but would 
expand the use of ICP monitoring for the management of chronic intracranial 
hypertension and enable further clinical research into these disorders.  The 
research herein reviews the current challenges of existing ICP monitoring 
systems, develops a new novel sensing technology, and evaluates the same for 
potentially facilitating long-term implantable ICP sensing.  Based upon the 
findings of this research, this dissertation proposes and evaluates a dual 
 v 
matched-die piezo-resistive strain sensing device, with a novel in-vivo calibration 
system and method thereof, for application to long-term implantable ICP sensing.   
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CHAPTER ONE  
INTRODUCTION AND GENERAL INFORMATION 
The human body is comprised of various organs that generate, or are subject to, 
a variety of pressures.  These pressures are primarily induced externally due to 
gravity and include atmospheric compression and body weight opposition.  
However, there are also a wide range of pressures induced within the body itself.  
These pressures include those generated by the cardiovascular system, urinary 
system, digestive tract, musculoskeletal system, central nervous system, among 
others.  Most of these pressures are critical for good health and require precise 
regulation.  Blood pressure within the cardiovascular system and intracranial 
pressure (ICP) within the central nervous system, arising from the generation of 
cerebral spinal fluid (CSF), are two such components that must be precisely 
maintained.  The ability to continuously monitor these pressures would allow for 
early detection and intervention in the event autoregulation becomes impaired.  
To date, long-term ICP sensing remains a challenge, primarily due to sensor 
inaccuracies over long periods of time. 
With the advancement of micro-electro-mechanical system (MEMS) elements, 
low power inductively charged electronics, standardized wireless methods, as 
well as wireless hand-held computing devices, it has recently become feasible to 
potentially realize long-term telemetric implantables for physiological monitoring.  
ICP pressure is one such candidate that is desirable for telemetric monitoring.  It 
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is among the most critical pressures found within the body whereby intracranial 
hypotension can lead to ruptured blood vessels and hematomas while 
hypertension can lead to decreased blood perfusion within the brain.  Either case 
is quickly life threatening and affects one- to two-percent of the population 
congenitally by hydrocephalus, or is acquired due to brain tumor, traumatic brain 
injury, or from arachnoid villi damage from meningitis, for example.  The work 
herein seeks to overcome the challenges of ICP monitoring where high-
resolution pressures, on the order of several millimeters of water, must be 
measured in-vivo with low drift over long periods of time (e.g. years).  This 
research undertakes a review of the scientific literature to assess the current 
challenges of ICP monitoring and to develop a new novel approach for 
overcoming the fundamental limitations of long-term implantable ICP sensing, 
particularly measurement drift.  The goal of this work is for the research and 
initial evaluation of a novel biopressure sensor system to serve as a platform 
technology for accurate and clinically relevant long-term measurements of ICP.   
Intracranial Pressure and Disorders Thereof 
Pressure within the cranium is due to the arterial and venous pressure acting 
against the pressure head of the intracranial contents.  Blood flow to the brain, 
characterized by cerebral perfusion pressure (CPP), is commonly calculated 
using ICP and mean arterial pressure (MAP) using the relationship CPP = MAP – 
ICP.  Intracranial pressure is normally generated primarily from the formation of 
cerebral spinal fluid (CSF) and is a result of the pressure-volume relationship of 
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incompressible fluids within the semi-rigid intracranial compartment.  Therefore, 
any changes in the volume of the intracranial contents alters ICP.  CSF is 
primarily formed by the choroid plexus within the first and second lateral 
ventricles of the brain, illustrated in Figure 1, where it thereafter flows into the 
third and fourth ventricles.  Flowing from the ventricles, CSF then surrounds the 
spinal cord and subarachnoid space, where it is reabsorbed by the arachnoid 
villi.  CSF pressure varies in human beings, but generally falls within the range of 
68 to 136 mm H2O in normal adults in the recumbent position [1, 2] although 
some clinicians cite normal pressures as high as 180 mm H2O or 200 mm H2O 
[3, 4].  In the upright position, ventricular pressure is typically around atmospheric 
(i.e. ~0 mm H2O) or even negative due to gravitational forces upon the spinal 
fluid column [4]. 
 
Figure 1 – CSF generation within the brain. 
(Source: Gray's Anatomy of the Human Body, 20th edition) 
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Abnormalities occur when there is an over generation of CSF by the choroid 
plexus or a malabsorption of the fluid by the arachnoid villi, such as that with 
hydrocephalus.  Abnormal pressures can also result when restrictions or 
obstructions in the fluid pathway retard or prevent CSF reabsorption.  These 
obstructions can often be congenital but may also result from brain tumors or 
head trauma.  Figure 2 shows an axial MR brain scan where enlargement of the 
lateral ventricles has occurred as a result of abnormally high ICP. 
Koskinen showed that for pathological patients under study in the neuro-ICU, 
patients’ average ICP was 249 mm H2O, measured intraventricularly [5].  For 
hydrocephalus patients, who suffer from chronic intracranial hypertension (ICH), 
a CSF shunt is the most common treatment for maintaining normal pressure 
levels and for preventing dangerously high levels of ICP.  A shunt diverts excess 
CSF to a resorptive site, commonly in the peritoneum, within a small catheter 
lumen including a pressure threshold check valve.  Without a shunt, or 
equivalently in the case of a failed shunt (e.g. due to an obstruction), a patient’s 
condition may quickly become life threatening as ICP overcomes MAP, thereby 
restricting CPP.  Short of other interventions, such as 3rd ventriculostomy or 
temporary external ventricular drainage, untreated hydrocephalus is typically fatal 
[6, 7].  
Lundberg additionally indicated severe ICP has been shown to extend even 
beyond 500 mm H2O [8].  Young reported extreme ICP levels in excess of    
 5 
 
Figure 2 – Axial MRI showing enlargement of the lateral ventricles due to 
elevated ICP. 
(Source: Neurosurgery Center of Colorado) 
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680 mm H2O for severe head trauma patients who were provided atypical 
specialized treatments to maintain CPP above 60 mm Hg with notable success 
[9].  Nevertheless, for patients whose ICP exceeded 1,019 mm H2O (i.e. 75 mm 
Hg), Young reported brain herniation and fatal outcomes within 24 hours.  
Regardless, the case studies by Young with ICP’s above 500 mm H2O represent 
acute head trauma cases and not chronically elevated ICP’s typically associated 
with hydrocephalus. 
Typical methods for assessing intracranial pressure require a surgical procedure 
to install a ventricular catheter through the skull and thereafter measuring CSF 
pressure with an external manometer.  Another method involves the use of a 
tethered electrical or optical pressure sensor that can be inserted into the brain 
for localized in-vivo readings.  For example, optical pressure sensors are 
commercially available with a pressure transducer located at the tip of a fiber 
optic strand.  Fiber optic instrumentation is used to provide pressure read outs 
based upon interferometer techniques to detect translation of the pressure 
transducer’s diaphragm. 
While these methods provide in-situ assessment of intracranial pressure, they do 
so most invasively and only upon a temporary basis within a surgical or intensive 
care setting.  Typically, these types of pressure measurements are only carried 
out after a variety of other expensive diagnostics, such as medical imaging, have 
been exhausted in an attempt to explain the root cause of a patient’s illness.  
Once it is determined to proceed with invasive pressure measurements, the 
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patient is often sedated while the sensing element is surgically installed.  
Thereafter, the pressure sensor element remains temporarily tethered to the 
patient through a bore hole in the skull.  It is then necessary to place the patient 
under continuing hospital care in order to monitor the pressure over time.  
Therefore, these assessment techniques are unfortunately the most invasive and 
expensive approach possible.  They furthermore increase patient risk with the 
potential of surgical complications, such as infection, especially over prolonged 
periods [10].  Since intracranial pressure can rapidly rise due to an adult’s fixed 
intracranial volume, patients can quickly reach a critical state by the time all 
preliminary diagnostics have proven negative.  Therefore, a need exists for high 
risk patients to be able to routinely and non-invasively monitor ICP to prevent life 
threatening emergencies and to allow further research into ICP under various 
conditions or activities.  The work of this dissertation seeks to advance the field 
of research of this problem by investigating the limiting factors preventing long-
term ICP monitoring and potential solutions thereof.   
Standard Intracranial Pressure Measurement Techniques 
The “gold standard” method of assessing ICP is through the introduction of a 
catheter, connected to a manometer, into the ventricles of the brain by way of a 
bore hole though the skull, as shown in Figure 3 [11].  A saline solution is used, if 
needed, as a translating fluid medium to allow external alignment of the 
measuring solution with that of the ventricular cavity.  Fluid elevation beyond that 
of the internal cavity ceiling level is then measured to arrive at a pressure relative  
 8 
 
Figure 3 - Intracranial pressure monitoring with a ventricular catheter. 
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to atmospheric.   This technique allows for robust pressure measurement that is 
immune to drift and which also facilitates drainage relief as necessary.  However, 
the method is also the most invasive of all techniques with studies indicating up 
to an approximate 10% infection rate [12, 13]. 
A popular alternative to manometer pressure measurements is that provided by 
optical pressure transducers, such as those marketed by FISO [14] or Natus [15].  
In this technique, a fiber optic strand with a pressure sensitive tip is inserted into 
a ventricular catheter or into the parenchyma and is read out by interferometer 
instrumentation bedside to the patient.  Figure 4 shows such a fiber optic sensor 
whereby the strand is configured with a pressure sensitive membrane that 
translates relative to incident pressure.  A collimated light source present within 
the fiber and reflecting off the sensor membrane varies the amount of reflective 
constructive or destructive interference.  Therefore, the amplitude of the reflected 
light received at the proximal end is proportional to the pressure present upon the 
membrane tip.   Drift and temperature effects have been widely reported with 
such sensors, however [2, 11].   
Since the fiber optic method is optically based, using interferometry against an 
absolute pressure reference, and given there are no present devices with 
temperature sensing and correction, the pressure drifts with temperature.  Drift 
reported for fiber optic pressure sensors may predominately be due to the sensor 
being “zeroed” ex-vivo at room temperature and then actual pressure 
assessments taken in-vivo at a temperature of approximately 37°C.  Additionally,  
 10 
 
Figure 4 – Fiber optic pressure sensor. 
(Source: Sensors by Questex Media Group LLC) 
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since these types of sensors typically deflect more than the thickness of the 
pressure diaphragm itself in order to reach desired sensitivities, the diaphragm 
operates within a non-linear range of deflection, which can extend into plasticity 
and result in hysteresis.  Piper reported that their data indicated more than half of 
34 fiber optic pressure transducers explanted had zero drift in excess of 40 mm 
H2O [11].  
In addition to fiber optic pressure readout systems, additional prevailing 
techniques include the use of an implantable strain gauge inserted into the 
brain’s ventricles or parenchyma.  Commercial offerings, such as those 
manufactured by Codman (under Integra Life Sciences) [16], offer a titanium 
probe with a side sensor providing electrical communication of pressure from the 
transducer to a bedside readout system.  The Codman sensor consists of a solid 
state piezoresistive diaphragm and a Wheatstone bridge readout circuit [2].  As 
pressure modulates the diaphragm, induced strain changes the resistive 
properties of the material.  The Wheatstone circuit converts this variable 
resistance into a proportional electrical current representative of the sensor’s 
incident pressure.  Advantages of this silicon technique include the option of 
temperature compensation based upon in-vivo silicon bandgap measurements.  
Assessments of the Codman strain-based sensor (also referred to as a 
microstrain device) have shown minimal drift, an average of 12 mm H2O, and 
with pressures that correlate accurately with direct intraventricular ICP 
measurements [2, 5].   
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While other methods of ICP exist, including qualitative non-invasive techniques 
discussed within the Literature Review, the formerly described intraventricular 
catheter manometer, fiber optic sensor, and strain gauge sensor comprise the 
extent of prevalent and contemporary means of quantitative clinical assessment.   
Challenges of Intracranial Pressure Monitoring 
The primary challenge of monitoring ICP is accuracy balanced against risk.  The 
most accurate methods are invasive, ranging from lumbar puncture to various 
cranial access approaches, including ventriculostomy.  Accuracy is diminished by 
pressure sensor drifts, which have been shown to range from 1 - 3 mm Hg (14 – 
41 mm H2O) in just five days, significantly reducing clinical efficacy, especially for 
longer term use [29].  Lumbar puncture has severe limitations with accuracy [17].  
Ventricular cannulation remains the gold standard for the most accurate ICP, but 
carries the highest risks, which are associated with brain penetration (e.g. 
placement, hemorrhage, etc.) and infection.  Infection rates for a ventriculostomy 
currently range from 8 – 10% [12, 13].  However, rates for intraparenchymal 
sensing reside at approximately only 1 - 2% [18].  Other invasive methods, such 
as subarachnoid, subdural, and epidural devices have proven unreliable and are 
not commonly used in clinical practice [19].  In all invasive methods, with 
exception to telemetric sensors which are also currently limited in accuracy, the 
sensor is tethered to a bedside receiving unit, limiting ambulation and increasing 
infection risks.  With regard to non-invasive approaches, all are currently 
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qualitative, at best, as Robba recently summarized, there were no prevailing non-
invasive techniques to justify substituting for current invasive approaches [20]. 
Significance and Contribution 
Hydrocephalus is presently reported to congenitally afflict between 0.5 to 3 out of 
every 1,000 live births [21, 22, 23, 24].  However, the disorder can also be 
acquired from pathologies such as brain tumors, head injury, meningitis, or as a 
result of intracranial hemorrhage, which altogether represents about 40% of all 
cases [25].  Procedural statistics from the American Association of Neurological 
Surgeons (AANS) estimated approximately 70,000 U.S. shunt procedures were 
performed in 2011 while the Hydrocephalus Association currently reports over 
one-million people in the U.S. are living with the disorder [24, 26].  Procedural 
costs in the U.S. have been estimated at an average $35,816 per admission 
thereby placing the total cost burden in the U.S. into the billions of dollars 
annually [27]. 
Although credited to Nulsen and Spitz in 1951 for the first fully internalized shunt, 
Richard Ames initiated what has now became the most prevalent shunt of 
modern times when he first implanted the ventriculoperitoneal (VP) shunt in 1958 
comprised of silicone rubber [28].  Silicone was first implanted via a shunt by 
Pudenz in 1957 for the lesser common, at least in the U.S., ventriculoatrial shunt 
[29].  Nine years thereafter Ames reported promising results, for an otherwise 
typically fatal disorder, indicating successful VP shunt implants in an additional 
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120 patients [30].  Still today, shunts are the predominant lifesaving treatment for 
hydrocephalus, yet unfortunately have about a 50% failure and revision rate by 
the second year of implantation and 70% to 88% by year ten [31, 32, 33, 34].   
Shunt failure is commonly associated with the onset of a headache and can 
thereafter quickly turn lethal [35, 36].  However, headaches are also typical of 
shunt mis-adjustment resulting in either under-drainage or over-drainage.  Antes 
et. al. recently described that shunt malfunction, as well as under- or over-
drainage, is difficult to diagnose and with shunt radiography and cranial imaging 
often remaining inconclusive [37, 38].  The problem is further aggravated when a 
patient is not in a state to sufficiently describe their symptoms.  Verification of 
intracranial pressure then entails costly and risky invasive techniques for the 
measurement of ICP, as described in detail within the Literature Review.  Such 
invasive techniques are the only current and clinically accurate means of 
assessing ICP, either for shunted patients suspected of shunt malfunction or for 
patients initially succumbing to intracranial hypertension for other reasons (e.g. 
brain trauma, lesions, edema, hemorrhage, etc.). 
The benefits of being able to accurately and telemetrically measure ICP are 
numerous and immense.  Within the literature, many investigators have 
considered ICP-guided valve adjustments by using telemetric ICP measurements 
as one of the most forward-looking advancements in hydrocephalus 
management [39, 40, 41].  Benefits are obvious for diagnosing potentially 
dangerous, yet unspecific headaches, particularly for those whose clinical 
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symptoms cannot be easily correlated to over drainage or underdrainage [42].  
Authors have cited a long-standing need for telemetric ICP technology which 
would reduce costly imaging dependency for patient monitoring and obviate the 
need for additionally implanted shunt devices [43, 44].  Furthermore, ICP 
surveillance for patients who have suffered from traumatic brain injury (TBI) has 
been one of the most intended indications for long-term ICP measurement.  
Latent ICP peaks and the development of secondary hydrocephalus could be 
recognized earlier with regular monitoring to reduce the chances of further brain 
damage [37].  Moreover, verification of shunt alternatives, such as endoscopic 
third ventriculostomy (ETV) could be more efficiently enabled to distinguish ETV 
responders versus non-responders as shown by several recent case studies [37]. 
As shown in the Literature Review, pressure measurement accuracy has been, 
and remains, the limiting factor for the deployment of a long-term ICP device.  
Even for clinically current mainstream tethered devices, such instrumentation is 
limited by so-called “zero drift” even though it may be from baseline or sensitivity 
drift, or both.  Drifts of 1-3 mm Hg (i.e. 14 – 41 mm H2O) have been reported over 
the course of just five days for prevailing ICU tethered instrumentation, 
diminishing clinical usefulness [45].  Recent commercial attempts for wireless 
ICP sensor implants have validated the needs of the market for telemetric ICP 
assessment.  However, clinical reviews of the commercialized technology have 
shown that marked and unpredictable drifts in accuracy limit broad use, 
rendering such implantable sensors unreliable over the long-term [38].  
 16 
Nonetheless, these reviews state that effective ICP monitoring over long periods 
outside the clinic is highly desirable and beneficial for optimizing treatment.  In a 
2016 review, Robba summarized there were no then-current non-invasive 
techniques accurate or established enough to substitute for current invasive 
measurements [20].  Subsequent reviews of the literature and industry performed 
herein have concluded the same, as of time of writing. 
Long-term pressure sensor drift is the persistent culprit that prevents the much-
needed diagnostics for millions of people suffering from hydrocephalus, traumatic 
brain injury (TBI), and other causes of intracranial hypertension.  A recent paper 
reviewing the challenges and state of the field for enabling chronically 
implantable pressure sensors found it crucial to have a means of drift 
compensation circuits or zeroing functions to provide correction [46].  Described 
and researched herein is a novel solution for non-invasive offset and gain 
calibration based upon dual matched biopressure sensors utilizing an in-vivo 
hydraulic reference for negating sensor drift.  The research described herein 
resulted in the award of United States patent 9,668,663, having been reviewed, 
in light of the prior art, for novelty, inventive step, and utility [47].  The device and 
method utilizes two matched silicon piezoresistive strain sensors and a common 
gas reference to facilitate corrected ICP measurement by one sensor based 
upon an in-vivo reference measurement from the other.  The device confronts 
reference degradation and other sources of potential drift in common-mode to 
first reduce drift and then to leverage matched sensor die characteristics for 
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applying correction coefficients measured by one sensor for application to the 
other.  Deployment of the sensor would allow forthcoming patients to calibrate 
the wireless sensor by either using a two-position method (e.g. supine to upright) 
or by utilizing natural changes in barometric pressure.  
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CHAPTER TWO  
LITERATURE REVIEW 
Overview 
Over the past decade several authors, including Wiegand [17] and Raboel [48], 
have provided comprehensive reviews of the methods and instrumentation for 
measuring ICP.  Hawthorne and Piper [49] published an extensive review in 2014 
focusing upon ICP for traumatic brain injury (TBI), including historical 
perspectives citing Alexander Monro’s (1697–1767) original publications on 
intracranial contents.  In 2017, Zhang et. al. [18], published what is today’s latest 
review, covering a growing set of research earnestly seeking improvements in 
ICP instrumentation.  The literature review herein summarizes the present 
technological state of ICP instrumentation, extending beyond the latest published 
reviews, with a particular emphasis on the research and development of 
completely implantable transponder approaches.  This chapter organizes the 
literature survey into both direct methods for measuring ICP (all of which are 
invasive or initially invasive) and indirect methods in which physiologically related 
measurements may be proportional to actual ICP. 
Direct ICP Measurement 
Early direct measurement techniques for assessing ICP was pioneered by 
Lundberg and described in his landmark 1960 publication [8] for the continuous 
pressure monitoring of 130 patients.  His technique employed a saline based 
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subdural pressure transducer deployed via ventricular cannulation.  Wiegand, 
Raboel, Hawthorne, and Zhang all ascribe intraventricular monitoring as the 
enduring gold standard of modern day accurate ICP measurement.  Zhang’s 
assessment attributed invasive methods, such as intraventricular monitoring, as 
the most accurate of measuring ICP.  Nevertheless, all agree of its shortcomings 
with regard to infection rates over time, the potential for brain hemorrhage, and 
the difficulty of successfully performing a ventriculostomy under elevated ICP 
where a deviated or slit ventricle may be present.   
Alternatively, modern day electrical based pressure probes may be utilized such 
as the fiber optic [15] or electrical impedance strain transducer [16].  These 
sensors can be used either within the ventricle or the parenchyma.  Luerssen 
described that these modern-day parenchymal sensors are comparable with that 
of the intraventricular hydrostatic methods and that the complication rate is lower 
due to the small diameter of the probes and lack of fluidic coupling [50].  
Luerssen cites Pople [51] and Shapiro [52] as two large studies resulting in less 
than a one-percent infection rate for pressure measurements taken within the 
parenchyma.  For ventricular cannulation, however, Luerssen cites several 
studies indicating infection rates approaching ten percent [12, 13].  He describes 
the risks of infection increasing with duration of monitoring and for this reason 
should only be used for as brief a period as possible.  He further cited studies 
showing that prophylactically changing the ventricular catheter used for pressure 
measurement did not reduce the risk of infection. 
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Direct Fiber Optic Measurement 
Fiber optic pressure transduction utilizes a thin diaphragm, often constructed 
from a silica fiber itself, comprising a sealed cavity in order to measure 
diaphragm deflections from incident pressure against an absolute pressure 
source.  Optical interferometric techniques are used in order to measure the 
diaphragm translation.  Piper et al. questions, however, the efficacy of the fiber 
optic parenchymal or intraventricular pressure probes as a means of accurate 
direct measurement.  Their research found drifts for the Camino fiber optic 
system in excess of 40 mm H2O for 50% of the pressure probes tested within a 
period of days [11].  While the manufacturer of the sensor studied specifies an 
upper bound on drift of ±27 mm H2O for day one and 13.6 mm H2O for each day 
thereafter, Piper claims this is unacceptable for clinical use.  Further, researchers 
have even confirmed zero drift in excess of the specifications, with average daily 
drifts of 43.5 mm H2O, in a study of 136 Camino fiber optic sensors [53].  Such 
large drifts were also found in an additional study of 1,000 clinical cases utilizing 
the Camino monitor with 87% of the cases drifting from -231 mm H2O to 285 mm 
H2O over a mean period of only 58 hours [54].   
The study by Piper et. al. showed significant drift bias with a dependence on 
temperature for the fiber optic sensor.  Studies have indicated a potential reason 
for such clinical drift is that the absolute pressure sensors are calibrated (i.e. 
“zeroed”) ex-vivo at room temperature (e.g. ~20°C) and then measured in-vivo at 
body temperatures, typically at 37°C [55].  A temperature coefficient of 4 mm 
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H2O per °C likely results in a significant pressure error versus the calibration [11].  
For a 17°C temperature shift, a 68 mm H2O error would result.  However, once in 
the brain, temperatures are relatively stable.  Figure 5 illustrates temperature 
measurements taken in over 100 sites in 16 monkeys involving 347 experiments 
[56].  The values shown are site temperature measurements less aortic arterial 
blood temperature (all positive values).  From the brain’s surface to its ventricles, 
a gradient of 0.4°C was documented.  Brain temperatures shifts were found to 
overall closely track venous blood in the right atrium.  From sleep to arousal, 
brain temperature increases of approximately 0.2°C were found. 
While pressure sensor inaccuracy, particularly at time of implant, likely occurs as 
a result of the fiber optic’s thermal coefficient, there are other possible factors 
that may explain post-implant drift as well.  Degradations resulting from 
mechanical drift mechanisms of the optical diaphragm material, readout 
electronics, and the systems interconnects may each further contribute to drift 
over time.  For sufficient sensitivity, the optical diaphragm must be very thin.  
However, pressure deflections may often be larger than the thickness of the 
material itself.  While small deflections can be predicted linearly as with a normal 
round circular plate [57], large deflections quickly turn non-linear [58] and can 
extend into plasticity for the material.  Once the deflections become plastic, 
distortion effects occur where deformity can result in hysteresis and therefore 
drift.  Additionally, atmospheric pressure changes over the course of in-vivo 
measurements have also been suggested as possible drift factors in the Camino  
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Figure 5 – Thermal map of primate brain for two frontal sections (14.3 and 0.3). 
(Source: The American Journal of Physiology, Hayward and Baker, 1968) 
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sensor system, which are likely given its measurements are relative to a single 
absolute reference source [59].   
Direct Microstrain Measurement 
In contrast to the direct fiber optic intraventricular or parenchymal probe reviews, 
microstrain based sensors (i.e. piezoresistive pressure sensors) have received 
relatively positive appraisals within the literature.  Koskinen performed a 
prospective study using the Codman Microsensor System (i.e. microstrain 
sensor) with 128 patients whereby zero drift was measured upon explantation [5].  
The study additionally performed 469 measurements on 22 patients that also 
simultaneously used an intraventricular manometer for comparison.  Results 
were shown for the 22 patients to have an average ICP of 249±4 mm H2O 
measured intraventricularly.  The microstrain based device produced an average 
of 258±3 mm H2O over the range of patient ICP.  The overall mean drift across 
the span of 7.2 ± 0.4 days was reported at 12 mm H2O (i.e. 1.67 mm H2O per 
day) with bounds less than ±27 mm H2O in 79% of the devices.  Koskinen 
reported the findings from a clinical point of view as acceptable and that the drift 
was low.  A separate study of 88 patient cases utilizing the Codman Microsensor 
System in two separate neurointensive care units also found a mean drift of ±27 
mm H2O over a mean monitoring time of 108 hours [60].  An additional study 
further confirmed similar performance in 60 cases using the Codman ICP monitor 
whereby 43% of the cases demonstrated essentially zero drift while another 40% 
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was within ±14 mm H2O.  Maximum drift in all cases was reported to be 41 mm 
H2O [61]. 
Spiegelberg also produces brain pressure monitors based on strain gauge 
technology, but with a different approach allowing in-vivo recalibration.  The 
Spiegelberg monitor utilizes a sealed disposable air-pouch catheter transducer 
which is semi-inflated by an accurately calibrated air pump [62].  The air pouch 
catheter may be placed intraventricularly or within the parenchyma and further 
provides simultaneous CSF drainage via a separate yet integrated lumen.  The 
resulting internal air pouch pressure is measured against the pump pressure to 
deduce ICP.  The advantage is two-fold: 1.) the pressure sensor remains ex-vivo, 
whereby it can be recalibrated without need to remove the catheter, and 2.) the 
system can optionally facilitate brain compliance measurements by further 
displacing a small portion of brain volume (<0.1 ml) while another sensor 
measures the ensuing rise in ICP.  Drifts for the Spiegelberg brain pressure 
monitor have been shown to be ±41 mm H2O over 28 days [63].  
Another ICP monitor also employing strain gauge technology is the 
LiquoGuard®7 manufactured by Möller Medical, introduced in 2011 following the 
original LiquoGuard.  The LiquoGuard7 is similar to Spiegelberg’s ICP monitor, 
allowing for simultaneous ICP measurement while draining CSF.  However, the 
LiquoGuard7 is unique in that it regulates drainage via a closed-loop control 
system comprising ICP measurement feedback to maintain a desired pressure 
setpoint within the brain [64].  In this way, the system relieves intracranial 
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hypertension by controlling the drainage of CSF electronically, not by gravity 
alone.  The benefit of this feature over other external ventricular drainage (EVD) 
systems is that there is no need to level a burette to control CSF pressure and 
flow.  Therefore, patient ambulation is less restricted.  For reliability and safety, 
the monitor incorporates redundant systems for sensing pressure utilizing two 
separate and independent strain gauge sensors each with independent 
processing circuits.  The sensors are integrated into the CSF drainage lumen and 
attached to the patient at the level of the Foramen of Monro [65].  Optionally, the 
control system may be simultaneously connected to a separate ICP monitoring 
system for the measurement of ICP under conditions such as slit ventricles.  The 
system modulates CSF drainage, based on pressure sensor feedback, by 
mechanically constricting its CSF drainage lumen using a pinch valve.  CSF flow 
is gravitationally driven by the pressure difference between that of the ICP and a 
burette, or drip chamber, located at an elevation set lower than a patient’s 
ventricles [66].  However, in a regulatory disclosure of the device, a peristaltic 
pump is described as being used when ICP exceeds a preset threshold [67].  
Drift of the device is largely unreported although the manufacturer indicates the 
device drifts less than 14 mm H2O under long-term testing.    
Samaun et. al. [68] described some of the early work of silicon microstrain 
sensing for biomedical instrumentation, in particular for intravascular cardiac 
measurements.  In their work they developed a thin silicon pressure diaphragm 
for the measurement of low stress with orthogonally oriented p-type implanted 
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piezoresistors.  They go on to describe proper orientation for achieving 
magnification of stress measurement through the use of a bridge network in 
which two resistors decrease resistance upon induced strain while the other two 
likewise increase.  Properties of pressure detection with diaphragm mechanics 
were also thoroughly described in which sensitivity increases by the square of 
the ratio of the diameter to the diaphragm’s thickness.  Additionally, linear 
regions of operation were described to be limited to about 40% deflection 
compared to the thickness.  The researchers fabricated two piezoresistive 
sensors in which a sensitivity of 83 µV/Vsupply/mmHg and 14 µV/Vsupply/mmHg 
was achieved for diaphragm diameters of 1.2 and 0.5mm, respectively.  After 
calibration and temperature compensation their work resulted in pressure 
sensors accurate to within 1 mmHg (13.6 mm H2O) and with a range of up to 150 
mmHg (2,039 mm H2O).  However, Samaun described drift issues with the silicon 
microstrain sensing technique where temperature sensitivity of the diffused 
piezoresistors was significant, but correctable.  Additionally, Samaun found that 
mechanical creep due to different expansion coefficients between the sensor and 
mounting also contributed to drift over time and could very well dominate long-
term drift. 
Yurish [69] reviewed a variety of techniques concerning the readout of piezo-
resistive strain sensors.  His review covered high end analog to digital 
approaches and more cost sensitive microcontroller readout techniques.  
However, he cautioned against clock trigger noise affecting readout with direct 
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microcontroller techniques.  Yurish provided an overview of modern-day 
application specific integrated circuits (ASIC) available through commercial 
means for the dedicated readout of microstrain sensors.  Most of the ASICs 
provided digital outputs via either I2C or SPI.  He cited Smartec as offering a 
pulse width modulated (PWM) output, but that it was only compatible with 
resistive bridges ranging from 10Ω to 250Ω.  Yurish noted that often, for remote 
sensing applications, the sensor’s signal is converted to a frequency or duty 
cycle signal.  Yurish’s work consisted of developing a variable frequency output, 
representative of the entire bridge resistance, with a variable duty cycle 
representative of the bridge’s unbalance for a very wide variety of bridge 
parameters.  In this way, Yurish approached the problem of bridge temperature 
variation by encoding the common mode effects into the circuit’s frequency 
output and the bridge’s strain signal into the duty cycle. 
Similar to Yurish, Crescini et. al. [70] also developed a readout circuit for a piezo-
resistive pressure sensor, but with the intentions of high temperature 
applications.  Crescini’s readout circuit measured the overall bridge resistance of 
the sensor and encoded this into an output square-wave carrier frequency.  The 
duty cycle of the square wave depended upon the imbalance within the bridge, 
representing the incident pressure.  Crescini, in agreement with Yurish, explained 
the advantage of such an approach in that the electronics could be safely located 
away from the sensor with a minimal degradation in accuracy.  Important to 
Crescini’s application was that the implied temperature was encoded by the 
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carrier frequency.  Crescini claimed the sensor’s output transmission was highly 
noise-immune and could be directly interfaced to a microcontroller for A/D 
conversion. 
Other Direct Techniques and Modern Approaches 
Capacitive based sensors are not currently prevalent within clinical practice for 
ICP measurement, but nevertheless have been attempted in the past and are a 
topic of study within the bioMEMS area of research.  George, et. al. recently 
described fabrication of a micro-electro-mechanical (MEM) based capacitive 
catheter sensor for ICP measurement [71].  In this type of sensor, metal upon a 
silicon die was used to form a variable capacitor whereby one electrode was 
fixed and a second was moveable in response to fluid pressure.  George 
reported typical sensitivities for such sensors on the order of tens to hundreds of 
atto Farads per millimeter of mercury (i.e. 13.6 mm H2O) with a fabrication 
tolerance of only about ±5%.    George went on to summarize that not only was 
the sensitivity of their device low and not well controlled, but that a large offset 
was present as well.  It is likely that George’s results are indicative of why such 
sensors are not as prevalent within the industry as strain and optical 
interferometry methods.  Stanford researchers Chen et. al. reported improved 
sensitivity gains utilizing a MEMS structure configured in a distributed resonant 
tank circuit fabricated from styrene butadiene styrene (SBS) elastomer [72].  The 
sensor was remarkably small at only 1 x 1 x 0.1 millimeters.  The team overcame 
traditional operating frequency limits and deployed the sensor in-vivo in a rat.  
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One issue, however, was drift in capacitance values that resulted from 
measurement cycling.  Additionally, there was drift due to the slow diffusion of 
water vapor through the polyimide substrate and adhesives, which caused a 
gradual decrease of the sensor’s resonant frequency.  The diffusion of water into 
the material likely altered the material’s permittivity causing an increase in the 
effective permittivity between substrate layers.  This drift mechanism has also 
been described by others, including most recently by Behfar [73].  Capacitive 
based biopressure sensors for low-pressure measurements (i.e. <100 mm H2O) 
have additionally been subject to drift due to small amounts of biomatter 
accumulation, particularly for sensitivities less than a femto-Farad per millimeter 
of mercury. 
One successful deployment of capacitive based pressure sensing, however, is in 
the case of the CardioMEMSTM EndoSureTM sensor [74].  This sensor represents 
the latest commercialization work for wireless sensing of cardiovascular pressure 
monitoring, which incorporates a MEMs based capacitive pressure cell.  The 
sensor is installed with a stent graft during endovascular repair and is entirely 
passive, consisting only of an inductor, capacitor, and a diode.  The sensor 
operates via ex-vivo wireless power stimulation, which results in a resonant 
frequency proportional to pressure induced capacitance.  The resonant 
frequency is detected by an external radio receiver, which typically results in a 
sensitivity of 10 kHz per millimeter of mercury (i.e. 13.6 mm H2O) [75].  Allen also 
reports that typical frequencies for such a sensor operates around 30 to 40 MHz 
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and with Q-factors of approximately 50.  He indicated ex-vivo readout distances 
of approximately eight inches.  While the EndoSure device provides a novel 
means of cardiovascular pressure interrogation, the pressures levels associated 
with blood pressure only begin near the maximum of those necessary for ICP. 
Indirect ICP Measurement 
Indirect methods of assessing ICP are based upon measuring related 
physiological parameters that correlate to true ICP.  Indirect techniques may be 
either invasive or non-invasive.  This section of the literature review surveys 
invasive means for indirect ICP assessment while the next section surveys non-
invasive indirect methods.   
The oldest known method of ICP measurement utilizes lumbar puncture and a 
manometer while a patient carefully lies in a lateral recumbent position [76].  
Commonly, the opening pressure (i.e. initial pressure) and closing pressure (i.e. 
after drainage of CSF) are used as potential clinical indicators of intracranial 
hypertension.  This technique works for communicating CSF (i.e. without 
obstruction) and provides an indirect measurement of ICP, albeit with significant 
disadvantages and inaccuracies [17] especially for patients under general 
anesthesia.  Czonsnka and Pickard [19] reported misleading ICP for instant fluid 
column measurements and suggested that such pressures should be averaged 
over at least 30 minutes or more preferably overnight. 
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Intraparenchymal sensing is likely the most contemporary prevalent method of 
overall ICP sensing [18].  Hawthorne described it as being the preferred 
technique of many centers even over intraventricular measurement [49].  Being 
indirect, the method utilizes a solid-state pressure sensor (e.g. fiber optic or 
microstrain) placed through a burr hole into the brain’s white matter within the 
non-dominant frontal hemisphere.   Wiegand describes intraparenchymal 
sensors as being the most reliable instrumentation available, easy to place, and 
with few infections (1 – 2%).  The same was supported by Luerssen [50].  He 
describes their use in Oxford, where surgeons have placed 583 devices, as of 
the time of publication, in which they (re)zero the devices daily to atmospheric 
pressure.  He indicated the intraparenchymal microstrain sensor (i.e. the 
Codman MicroSensor) was the device of choice in both emergency and elective 
cases at Oxford.  Several studies have shown microstrain parenchymal sensing 
to be as accurate as intraventricular measurement [5, 77].  
Other indirect invasive approaches exist, as illustrated in Figure 6.  
Measurements by epidural, subdural, or subarachnoidal access provide 
pressures which may be associated with ICP.  Subdural and subarachnoid 
measurements are quite rare in modern clinical approaches [17].  They require 
the use of bolts for anchoring to the skull with an open saline-filled lumen, placed 
just under the dura, connected to a transducer.  Weigand indicates they are less 
prone to infection than direct measurements (e.g. ventriculostomy), but may be 
compromised upon brain swelling blocking the lumen.  Roboel cited concerns for 
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intercompartmental pressure gradients and focal ICP elevations as a reason to 
choose intraparenchymal or intraventricular measurements instead [48]. 
With respect to epidural measurements for assessing ICP, pressure may be 
measured in between the skull and dura with a sensor facing the brain.  Zhang 
described the benefits of such measurement as a lower probability for infection, 
hemorrhages, and seizures compared to direct methods [18].  Further, in the 
case of an epidural measurement, the dura may be left uncompromised, avoiding 
the risk of a CSF leak.  However, there are concerns with the dura diminishing 
true ICP translation and overall the method’s accuracy has been deemed not 
support routine clinical use by some clinicians [17, 18]. 
 
Figure 6 - Illustration of various ICP measurement techniques. 
(Source: Harary, Dolmans, & Gormley) 
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Non-Invasive ICP Assessment 
All non-invasive approaches to ICP assessment are indirect, meaning they use 
physiologically related measurements that may be correlated, or proportional to 
actual ICP.  Sonography techniques allow for one such non-invasive assessment 
by measuring a patient’s optic nerve sheath diameter.  The optic nerve sheath is 
an extension of the dura mater, which is the tough outermost membrane 
enveloping the brain and spinal cord.  The perioptic nerve’s fluid is generally in 
communication with CSF, hence providing an avenue for ICP evaluation [78]. 
Studies [79] have shown that the nerve diameter, as assessed by transorbital 
sonography in the transverse plane, 3 mm posterior to the papilla, is linearly 
related to ICP and can be indicative of hypertension.  For patients under normal 
CSF pressures, the optic nerve sheath was found to have a mean diameter of 3 
mm.  However, for those patients of increased ICP, the optic nerve sheath 
diameter was found to average 5 to 6 mm.  While this non-invasive technique 
offers a quick and inexpensive method of qualitatively indicating elevated ICP, 
the deployment and efficacy of the method may require expert interpretation [17].   
Of recent development, and sparsely reviewed in the literature, is the potential for 
non-invasive ICP assessment by ultrasound measurement of the ophthalmic 
artery (OA).  The OA stems from the internal carotid artery within the cranium, 
transporting blood along the optic nerve to the orbit.  The OA is subject to ICP 
within the cranium, but not in the orbit where pressure is equal to atmospheric.  
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The diameter of the OA inside the cranium is smaller than within the eye due to 
ICP.  Consequently, blood flow velocity is higher intracranially than within the 
orbit.  Vittamed, founded in 2013 and associated with U.S. based Boston 
Neurosciences, is currently developing instrumentation for measuring the OA 
blood flow velocity within the cranium and within the orbit using a dual-depth 
high-resolution transcranial Doppler insonation [80].  The approach necessitates 
extracranial orbit compression to equate blood flow velocities in both locations.  
The equilibrium pressure is then interpreted as ICP.  Ragauskas reported results 
from a study of 62 patients where simultaneous recordings of OA based non-
invasive ICP measurements were compared to direct measured ventricular 
pressure [81].  Results showed low systemic error of 1.6 mm H2O with a 
precision of 30 mm H2O.  The authors suggested the OA method did not need 
calibration.  However, in a 2016 review by Robba et. al. the clinical practicality of 
the new method was questioned due to the uncertainty in locating the intracranial 
and extracranial segments of the ophthalmic artery [20]. Robba suggested that 
even if clinicians were to overcome doubts of being able to find the ophthalmic 
artery, then the technique would require highly skilled transcranial Doppler 
specialist with fine anatomical knowledge. 
Other non-invasive approaches to ICP have been proposed and researched 
within the literature.  For instance, the delay of visually evoked N2 electrical 
potentials, as measured upon a patient’s scalp, have been correlated to rises in 
ICP [82].  The challenge, however, is with the practicality of the clinical setup for 
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the measurement and interpretation of the delays, which may require 
neurophysiological expertise.  Neonatal fontanelle compression is yet another 
ultrasound method whereby an infant’s “soft spot” is compressed during Doppler 
sonography to examine the hemodynamic response.  While qualitative in nature, 
the technique provides a method of assessing progressive or persistent 
elevations in ICP for neonates with hydrocephalus.  Several literature reviews 
have categorized numerous non-invasive approaches into five categories 
consisting of fluid dynamics, ophthalmic, otic, electrophysiologic, and 
miscellaneous [18, 78].   Table 1 outlines the various techniques which have 
been researched and reviewed throughout the literature. 
Overall, with respect to the most current non-invasive approaches to ICP, all 
authors reviewed concluded that ventricular catherization remains the gold 
standard.  Furthermore, there was consensus that non-invasive ICP 
assessments were presently only qualitative and insufficiently accurate enough 
for routine clinical use to provide an alternative to invasive approaches [17, 18, 
20, 48].  Nonetheless, Wiegand attributed non-invasive assessments as clinical 
signs, complimentary to diagnosis, such as clinical history, physical examination, 
and radiological methods for the assessment of elevated ICP.  Altogether, non-
invasive solutions are desperately needed and therefore continue to be the topic 
of much research. 
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Table 1 – Non-Invasive ICP Approaches 
Non-Invasive ICP Method Category Measurement Technique 
Fluid Dynamics 
Magnetic resonance imaging (MRI); 
transcranial doppler ultrasonography 
(TCD); cerebral blood flow velocity 
(CBFV); near-infrared spectroscopy 
(NIRS); transcranial time-of-flight; 
Ophthalmic 
Spontaneous venous pulsations (SVPs); 
venous ophthalmodynamometry (ODM); 
optical coherence tomography (OCT) of 
retina; optic nerve sheath diameter 
(ONSD); pupillometry; 
Otic 
Tympanic membrane displacement 
(TMD); otoacoustic emissions 
(OAE)/acoustic measure analysis; 
transcranial acoustic (TCA) signals; 
Electrophysiologic 
Visual-evoked potentials (VEP); 
electroencephalogram (EEG); 
Miscellaneous 
Skull vibrations; brain tissue resonance; 
jugular vein analysis; 
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ICP Telemetric Approaches 
Transcutaneous communication with human implantable devices have been 
reported in the art comprising optical, inductive, or high frequency radio 
techniques as reviewed by Townsend [83].  An ICP transponder concept 
essentially encompasses wireless communications, and optionally power, to an 
implantable self-contained pressure sensor, which for ICP, could be deployed for 
either direct or indirect measurement.  It was first proposed by R. Stuart MacKay 
in 1965 with initial prototypes developed by Atkinson et. al. in 1967 for one of the 
most troublesome diseases, hydrocephalus [84, 85].  Atkinson developed an 
entirely passive transponder, shown in Figure 7, consisting of an inductor and 
capacitive based absolute pressure sensor (i.e. LC tank circuit) that operated 
around 70 MHz.     
The transponder’s frequency would vary with ventricular pressure as one side of 
the capacitor consisted of a stainless-steel diaphragm 8mm in diameter.  The 
Atkinson device was implanted in a 2-month-old infant. They described hesitation 
about deploying the sensor in either the epidural or subdural space as ICP may 
be dampened by scar tissue.  Rather, they coupled the sensor to a ventricular 
catheter.  The results were successful in that they detected changes in 
ventricular pressure, including variations with the patient’s respiration, but not 
arterial pressure pulses.  The system was reported to have 5 mm H2O of 
telemetric noise.  Atkinson reported of several problems including drift arising 
from stray capacitance, which reduced the sensitivity of the device, thought to be  
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Figure 7 – Transponder described by Atkinson et. al. [84] 
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from water absorption.  Furthermore, the absolute pressure sensor was subject 
to atmospheric pressure changes in which the authors described the “transensor” 
as an aneroid barometer or altimeter.  They additionally cited diaphragm 
materials as presenting an issue.  Nevertheless, development, testing, 
implantation, and operation of the device was a landmark for telemetric ICP 
sensing.  
Differential pressure sensors were deployed during the 1970’s as an improved 
attempt to circumvent atmospheric pressure changes [86].  Cosman developed a 
differential sensor for measuring subdural pressure, which would potentially 
negate atmospheric pressure changes.  The sensor was designed to provide 
accurate ICP by comparing to an external pressure palpated to the scalp above 
the sensor [87].  The transponder communicated by radio telemetry, similar to 
Atkinson, being based on an LC tank circuit.  Cosman’s approach would 
simultaneously detect the zero-point of the sensor corresponding to a balance of 
pressures across it (i.e. ICP – pressure by palpation).  This device was 
commercialized despite its 24% failure rate within the first week of implantation 
[44]. 
In 1988 a ten-year follow-up on the performance of an epidural telemetric sensor 
was reported by Gucer et. al [88].  Similar to prior work, it was also an LC tank 
circuit whereby a capacitor was the pressure sensitive element.  The device was 
implanted into 127 patients.  13 of the patients retained the sensor for between 4 
to 9 years.  Gucer and team evaluated the sensor for accuracy, longevity, safety, 
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and stability.  The sensor was found safe and enduring without even one 
infection.  Sensitivity was sufficient enough to pick up ICP waveforms.  However, 
drift was drastically unacceptable at 1.0 ±0.2 mm H2O per day.  The drift was 
responsible for patients telemetrically measuring 2,290 mm H2O, when they 
actually had normal ICP.  Biofluid intrusion was also an issue due to the 
packaging and diagraph fatigue. 
Despite numerous efforts throughout the past fifty years, no telemetric 
biopressure sensor device has attained the commercial success like that of the 
CardioMEMS for arterial blood pressure.  The transponder is altogether similar to 
that proposed by Atkinson, Cosman, and Gucer.  It is a battery-less device, 
excited by ex-vivo radio frequency (RF) energy in which the transponder 
responds with a resonant frequency based on an LC tank circuit.  Pressure is 
proportional to its capacitive sensor in parallel with an inductor.  The device is 
entirely encapsulated in glass, minimizing frequently reported drift mechanisms 
associated with biofluid intrusion in capacitive sensors [89].  Power transfer for 
the device likely lies around 300 µW with DeHennis and Wise reporting inductive 
power consumption for a similar device at 340 µW and Brancato the same at 300 
µW [90, 91].  The sensor is intended for at least a 3-year implant life, but drift 
data has not been made public or published, except for qualitative reports 
indicating it is low and acceptable for arterial pressure use [89].  However, such 
pressure ranges are approximately an order of magnitude larger than that 
necessary for ICP measurement. 
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Raumedic Neurovent-P-tel 
Modern developments in implantable telemetric ICP sensors include two recently 
commercialized European models: the Raumedic NEUROVENT-P-tel and the 
Miethke Sensor Reservoir [92, 93].  Both models are reportedly based on 
microstrain transducers.  The Raumedic device, shown in Figure 8, is a stand-
alone remote intraparenchymal sensor, completely passive, with first clinical use 
in 2010.  The device is currently approved in Europe for use up to 90-days.  It 
consists of three main system components: the transponder, the ex-vivo active 
antenna unit, and the storage monitor.  Pressure measurements can be taken at 
frequencies of 1 or 5 Hertz.  Specifications indicate an operable pressure range 
of -20 to +400 mm Hg with an atmospheric limit of 1,500 mm Hg.  Accuracy is 
specified at ±2 mm Hg with a sensitivity of 1 mm Hg [38]. 
Antes, et. al. with the Saarland University Medical Center in Homburg, Germany, 
reported use with the Neurovent P-tel device in 247 patients [37].  He describes 
the device as having a 3 cm long polyurethane sensor catheter with a diameter of 
1.67 mm for intraparenchymal placement, which Welschehold indicates is 
silicone coated.  Further he details that the sensor housing is made of ceramic at 
a diameter of 3.15 cm and a height of 4.3 mm.  The P-tel device is inductively 
powered and provides data transfer via load modulation. 
Out of 247 patients, only seven technical problems occurred with one being due 
to trauma.  The P-tel had a mean time of implantation of 46.9 days with a range 
between 3 and 90 days.  Antes reported the system was very easy to use and 
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Figure 8 - Raumedic NEUROVENT-P-tel [38] 
(Source: Welschehold, Schmalhausen, et. al.) 
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staff could be instructed within only a few minutes for operation.  Disadvantages 
were noted related to incorrect alarm settings or insufficient fixation of the 
sensitive antenna, interrupting ongoing measurements, sometimes for days. He 
also described that the readout module’s software was a weak point, lacking the 
ability to provide simple mathematical or statistical measurements (e.g. min, max, 
average, etc.).   
Antes cited a negligible zero-drift of about ±2.5 mm Hg but neglected to describe 
the interval or whether the zero-drift was measured or taken from a specification.  
Stehlin cited Raumedic as specifying a drift of ±2 mm Hg per year with the ability 
of the Neurovent-P-tel to provide reliable pressure data up to 18 months in-vivo, 
albeit regulatory limited to 90 days [44].  However, Welschehold et. al. in first use 
of the device cited a drift of ±2 mm Hg per 29 days [38].  Reports for Raumedic’s 
similar microstrain tethered monitor has measured a drift of 0.6 mm Hg after five 
days implantation into the parenchyma [49] and would more closely coincide with 
that reported by Welschehold.  Lastly, Antes described that a major shortcoming 
of the device was the limited 90-day implant period whereby a second surgical 
procedure was required to remove the probe.  He indicated the second surgical 
operation often deterred many potential candidates. 
Meithke Sensor Reservoir 
In 2015, Meithke similarly introduced a telemetric ICP sensor, shown in Figure 9, 
which integrates into a shunt’s Rickham reservoir, named Sensor Reservoir.  
Unlike the Raumedic counterpart, the Miethke device communicates directly with  
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Figure 9 - The Miethke SENSOR RESERVOIR  
(Source: Christoph Miethke GmbH & Co. KG) 
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CSF from the ventricle.  It consists of three main system components: the 
passive sensor implant, an ex-vivo active antenna/exciter unit, and a tethered 
handheld reader/display unit which can store pressure data on an SD card.  The 
manufacturer claims, that for the first time ever, the system is capable of 
assessing shunt function.  Miethke describes uses of the sensor encompassing 
non-invasive ICP detection, localization, and evaluation of occlusion in a shunt as 
well as shunt mechanical malfunctions [94].  The sensor measures 23.8 mm in 
diameter and 7.6 mm in height. 
Again, a team of neurosurgeons at the Saarland University Medical Center 
evaluated the implantable sensor in 25 patients over the course of a year.  Antes 
describes the sensor being housed in a polyether ether ketone housing with a 
silicone dome, similar to a shunt reservoir [42].  However, he states that unlike a 
conventional reservoir, the device also contains a titanium-covered measuring 
cell for noninvasive transcutaneous ICP measurement.  True to its name, the 
device can function as a reservoir and be tapped percutaneously for drug 
delivery or CSF withdrawal.  Contrary to other reports citing microstrain sensing, 
including the latest publication in 2018 from Harary, Antes reports that the sensor 
unit contains an application specific integrated circuit (ASIC) with 64 capacitive 
sensors [43]. CSF envelops the measuring cell and pressure is directly 
transmitted directly through the housing via a 12.0 μm titanium plate.  ICP values 
can be read out at a rate of 44 samples per second (i.e. Hertz).  Antes indicates 
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the implantation period of the Sensor Reservoir is unlimited and explanation is 
unnecessary with respect to regulations. 
Antes and team selectively deployed the Sensor Reservoir into 25 patients 
between December 2015 and November 2016 who were suffering from 
headaches.  They categorized measurements as normal ICP, underdrainage, 
over-drainage, and imbalanced CSF drainage.  A total of 183 telemetric 
measurements were taken during the period, which resulted in 85 valve 
adjustments.  Antes reported that obtaining ICP measurements was quick.  Such 
measurements and adjustments were reported to have positive clinical 
improvements in 18 of the 25 patients.  Interestingly, Antes reported that contrary 
to expectations, ICP was not well correlated with shunt valve settings.  Antes 
indicated this may be due to two possible reasons: 1.) short-term measurements 
may not represent average ICP, and 2.) valve setups utilizing both a differential 
pressure valve and a gravitational valve in series may influence drainage to an 
incalculable degree. 
Shortcomings of the device were reported as the thickness at 8 mm, especially 
for patients with thin skin.  Antes also described the desire to take continuous 
measurements over a one- to two-day periods to detect certain pressure leaks, 
pulse pressure, and pathological slow waves.  He further cited that the ex-vivo 
antenna was too large and heavy to facilitate fixation to a patient’s head.  Out of 
25 patients, two devices provided improbable ICP measurements.  One patient 
presented with slit ventricles and no sufficient ICP pulse signal was detected, 
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with ICP very negative.  The other patient’s device, placed into dilated ventricles, 
showed disproportionately high ICP values soon after insertion.  No comparisons 
to true ICP, measured by ventriculostomy, were presented.  As such, there was 
no report on measurement drift, but Antes did state he did not believe the device 
could remain accurate beyond five years.  
Research Gap and Limitations 
As described in the Challenges of Intracranial Pressure Monitoring section, 
pressure sensor accuracy, especially in terms of drift, remains an unsolved and 
prominent issue.  As a result, standard clinical practice necessitates the use of 
bedside tethered equipment which must be frequently recalibrated.  Infection 
rates associated with tethered ICP monitors range up to 10% for gold standard 
ventriculostomy measurements.  Avenues for eliminating tethered devices, and 
thereby reducing infection rates which increase over time, are restricted due to 
drift over the long-term (i.e. << months).  Clearly shown within the same 
Challenges section is the immense need, however, for such telemetric pressure 
sensing devices. 
Yu, in his review of the challenges and state of the field for chronically 
implantable pressure sensors, stated that sensors must possess a stable and 
consistent response over their lifetime [46] to be effective, of course.  However, 
to date, the state of technology for biopressure sensing has not achieved such a 
response to enable the very low-pressure measurements of ICP over a several 
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year lifetime of implantation.  Yu cited material aging and mechanical fatigue as 
primary contributors to both baseline (i.e. zero-drift or offset drift) and sensitivity 
(i.e. gain) shifts. 
Drift mechanisms have been researched and reported throughout the various 
sensors developed and cited herein encompassing atmospheric pressure or 
altitude changes, electrolytic biofluid intrusion, temperature changes, gas leaks, 
static discharge effects, among others beyond those described by Yu.  Efforts to 
mitigate these effects include Cosman’s work in the 1970s utilizing differential 
pressure sensors, including the application of a known external pressure to 
calibrate the subcutaneous sensor.  Additionally, development by Spiegelberg of 
their tethered monitor employing an air chamber transducer facilitates 
recalibration of external pressure sensors without removal of a 
catheter/transducer.  However, research and development to date has not 
revealed any methods to mitigate drift to a clinically acceptable level, either by 
reduction or calibration, to enable long-term implantation of a telemetric ICP 
biopressure transponder.   Both drift reduction and non-invasive in-vivo 
calibration for clinically acceptable ICP measurement is the pursuit of this 
research. 
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CHAPTER THREE  
MATERIALS AND METHODS 
Overview 
This research investigates the current limiting factors preventing long-term 
implantable ICP measurement.  Recognizing drift as the primary inhibitor, this 
work endeavors to minimize inherent pressure sensor drift and to mitigate both 
offset and gain shifts via a novel in-vivo calibration system.  Achieving such an 
advancement could possibly facilitate the world’s first ever accurate long-term 
(i.e. >>1 year) implantable ICP monitor.  Such a sensor system with this 
capability would allow for post-implant non-invasive ICP monitoring to provide 
early warning or confirmation of dangerously elevated ICP levels.  Furthermore, 
the capability to accurately measure ICP long-term would facilitate optimization of 
hydrocephalus shunt valves or even automated closed-loop systems. 
A review of the literature, assessing prior clinical research, was reported within 
the Literature Review for assessing the physiological approaches and variables 
of ICP measurement.  Additionally, a survey of sensing technology for ICP 
measurement was conducted and reported.  Within this chapter, requirements 
and research objectives are established for building upon prior research for 
enabling long-term ICP sensing.  Design considerations for a new novel 
biosensor are described in the following sections of the Approach.  Finally, 
methods for simulation and laboratory verification of a new novel prototype 
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sensor are outlined.    
Methods undertaken by this work include:  
1. A review of prior clinical research assessing the physiological approaches 
and variables to ICP measurement. 
2. A survey of sensing technology, including shortcomings or sufficiency for 
ICP measurement. 
3. Establishment of requirements and research objectives for a long-term 
ICP biosensor. 
4. Design of a novel custom sensing device and methodology for calibrated 
ICP measurement. 
5. Simulation of key design characteristics and uncertainties. 
6. Laboratory evaluation of selected sensing die technology for potential 
application in ICP sensing. 
7. Development of a prototype sensor with laboratory verification of key 
performance metrics. 
Requirements 
General requirements for the sensor include the use of biocompatible material 
interfaces, geometrically acceptable for implantation.  The sensor must further 
support non-invasive readout and ultimately provide clinically acceptable 
resolution and accuracy.  Overall, the biopressure sensor transponder (i.e. the 
entire sensing and telecommunicating implant) should provide reliable long-term 
operation, durability and, preferably, battery-less operation.  The sensor may 
 51 
preferably utilize transcutaneous energy to eliminate the need for a transponder 
battery, which may present hazardous toxic materials, or necessitate 
replacement via revision surgery.  The focus of this work is upon minimizing or 
mitigating sensor drift.  Specific requirements for the sensor follow within this 
section.   
The Association for Advancement of Medical Instrumentation (AAMI) provides a 
standard for intracranial pressure monitoring devices, with its latest revision in 
2015 [95].  The scope of the standard encompasses percutaneous fluid and 
electrically coupled sensing devices, common in today’s neuro-ICU wards, 
patient interfaces including sensor contact and display devices, and fully 
implantable type devices.  Its purpose is to provide labeling, safety, performance 
requirements, and test methods for assuring the safety and effectiveness of ICP 
monitoring devices.  The standard indicates its concepts are to be considered 
flexible and dynamic as advances are made in ICP monitoring technology.  
Relevant to the scope of this work, intended for initial research, development, 
and evaluation, the standard’s recommendation for pressure range, accuracy, 
and zero-drift will be considered.  
As previously revealed in a survey of the literature, Kimelberg and Ravi showed 
normal ICP to range from 0 to 136 mm H2O in the supine position, which can also 
become negative in the upright position according to Sotelo.  For shunted 
patients, negative pressures up to -440 mm H2O have been described due to 
siphoning effects, which can result in CSF over drainage [96].  Koskinen showed 
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pathological ICP to average 249 mm H2O with Lundberg showing extreme ICP’s 
of 500 mm H2O and beyond, particularly for head trauma patients.  The AAMI 
standard requires monitoring of 0 to 1,400 mm H2O.  However, given the 
standard’s broad scope and rationale, which includes bedside critical care acute 
monitoring for the critically ill, the upper end range of 1,400 mm H2O may be 
excessive for long-term monitoring of hydrocephalus patients.  Such long-term 
monitoring, as sought herein, is intended to provide ongoing ICP measurements 
to verify shunt functioning, optimization, and early warning levels prior to acute 
levels of intracranial hypertension.  As reported by Lundberg, pressures beyond 
500 mm H2O are considered severe.  Young’s research additionally showed that 
levels of 1,000 mm H2O or greater typically resulted in brain herniation and death 
within 24 hours.  While pressure monitoring of levels beyond 1,000 mm H2O 
would be desirably broad, such levels are associated with head trauma which 
necessitate acute care intervention and pressure monitoring.  Unnecessarily 
increasing the pressure sensing range for a long-term implantable monitor would 
reduce sensitivity and accuracy due to the pressure diaphragm’s configuration.  
Instead, given the variety of everyday patient positions, versus an acute care 
setting, it is important for long-term monitoring to allow for negative pressures 
range rather than an extended positive pressure only (i.e. 0 to 1,400).  Therefore, 
for this work, a pressure range of -500 mm H2O to +500 mm H2O will be adopted. 
Insight into clinically acceptable sensor resolution can be gained by examining 
hydrocephalus shunt valve resolutions.  Lollis et. al. performed a review of the 
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most prevalent programmable hydrocephalus valves on the market in 2010 
consisting of the Codman® Hakim® Programmable valve, the Medtronic® Strata® 
valve, and the Sophysa® Polaris® SPV valve [97].  The authors additionally 
reported on the Aesculap® ProGAV®.  However, this is an anti-siphon auxiliary 
valve used only in-line with a primary valve.  Out of all the valves Lollis reviewed, 
the Hakim Programmable valve had the best resolution of 10 mm H2O.  Upon 
further examining manufacturers’ present offerings, as of the time of writing, no 
valve currently marketed provided a higher setting resolution than the Hakim 
Programmable valve.  Medtronic’s valves provide a range of pressure-flow 
characteristics in which the Delta programmable valve’s Instructions for Use 
(IFU) indicates a setting tolerance range of ±40 mm H2O [98].  Maximum 
pressure range encompassing all the primary valves examined by Lollis was 200 
mm H2O, consistent with normal pressure levels reported by Drake and Sotelo.  
Therefore, given the highest resolution valve in clinical use resolves to 10 mm 
H2O, as of the time of writing, and given this would represent 1% of the sensor’s 
overall span (i.e. ±500 mm H2O), 10 mm H2O will be selected as the minimum 
clinically acceptable resolution for the pressure sensor system researched 
herein.   
In assessing the accuracy necessary for the sensor, it has been shown that 
adjustment of a valve’s setting by only 20 mm H2O or less can have clinical 
impact upon pediatric patients [99].  Therefore, to not introduce uncertainty 
beyond half this range, an accuracy of ±5 mm H2O will be set as an objective for 
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the system.  Likewise, the sensor’s precision objective will be targeted for ±5 mm 
H2O so as to not cumulatively extend beyond the 20 mm H2O range for clinical 
effect.  Combined, the sensor’s accuracy and precision objectives of ±5 mm H2O 
each results in a total possible error of ±10 mm H2O, or a 20 mm H2O range, 
which will be adopted over the span found by Lollis of 200 mm H2O.  This is 
within the AAMI standard’s requirement of ±20 mm H2O (40 mm H2O range) over 
a 0 to 200 mm H2O range.  Thereafter, the standard calls for ±10% maximum 
error and will be adopted for this scope of work as well. 
With respect to the sensor’s pressure drift, service life of the implantable sensor 
comes into question.  Prospective studies have shown the failure rate of CSF 
shunts is approximately 50% by year two and between 70% to 88% by year ten 
[31, 32, 33, 34].  Therefore, to serve the majority of patients with a diagnostic 
device complementing shunt treatment for both shunt optimization and as a 
diagnostic for shunt failure, the sensor will be planned for an expected 10-year 
service life.  The sensor serves two functions: First, pressure monitoring for valve 
setting optimization, maintenance, and research; Secondly, as a non-invasive 
indicator of shunt failure to distinguish alarming ICP values (e.g. >200 mm H2O) 
prior to escalating and dangerous ICP levels.  To distinguish alarming ICP, the 
sensor error should be less than ±50 mm H2O such that a measurement of 250 
mm H2O, for example, would confidently signal clinical intervention without 
potentially posing a false alarm (i.e. 200 mm H2O or less where a valve’s setpoint 
may be set).  At the same time, a 250 mm H2O measurement would not 
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erroneously allow drift error in excess of 300 mm H2O true pressure, well within 
the range of clinical intervention and management.  Therefore, over a 10-year 
service life, the sensor must not encounter drift, on average, of more than 5 mm 
H2O per year incrementally and successively over the service period (i.e. +50 
mm H2O or -50 mm H2O), which cannot otherwise be corrected by sensor 
calibration.  This performance metric will be considered separate from the sensor 
system’s accuracy at time of manufacture.  Drift specifications with the AAMI 
standard relate specifically to zero, or offset drift, and testing occurs over a 
minimum of 10-days at 0 mm H2O.  There is no specification within the standard 
related to drift other than the accuracy cited.   
Table 2 outlines the key requirements and research objectives developed as 
goals for this work.  The objectives are aimed at satisfying the key requirements, 
in part, as related to the scope of the sensor research herein.  Each objective is 
keyed and will be cited within Chapter Four’s Results and Discussion. 
Approach 
Sensor Technology 
Based on the literature review, among the various techniques and methods of 
measuring ICP, there are two dominant transduction means that have clinically 
demonstrated sufficient sensitivity for measuring the very low pressures of CSF.  
Both methods are based upon diaphragm translation, including microstrain 
sensing and fiber optic interferometry.  Results from Koskinen and Olivecrona  
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Table 2 – Key Requirements and Research Objectives Summary 
Top Level 
Requirements 
Key Requirements for 
Sensor Element(s) Research Objectives 
R1.0 The sensor 
must provide 
biocompatible 
interfaces. 
R1.1 The sensor must 
present a 
biocompatible 
silicon pressure 
diaphragm and may 
optionally include a 
long-term 
compatible parylene 
coated membrane 
or silicone gel 
coupling for 
pressure 
transduction.  Any 
other direct 
contacting 
materials, such as 
sealants and 
adjoining enclosure, 
must be 
biocompatible.   
O1.1 Justification of 
sensor to present a 
bottom-side bulk 
micromachined 
monocrystalline die 
surface for the 
pressure 
diaphragm to meet 
biocompatibility.  
Die must be 
capable of bonding 
to suitably hermetic 
biocompatible 
materials.  Sensor 
must withstand 
sterilization 
method(s). 
R1.2 Surfaces must be 
capable of being 
cleaned and 
undergo 
sterilization. 
O1.2 Device must be 
capable of 
sustaining a 
compatible wash 
and autoclaving, 
ethylene oxide, or 
gamma radiation 
sterilization without 
damage. 
  
→ 
O1.3 Surfaces must be 
capable of 
hermeticity to meet 
the intended 
service life of the 
implant. 
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Table 2 (continued) 
Top Level 
Requirements 
Key Requirements for 
Sensor Element(s) Research Objectives 
R2.0 The overall 
sensor 
transponder 
must be 
geometrically 
acceptable 
for 
implantation. 
  
→ 
O2.1 The sensor's 
transponder 
components must 
be capable of 
being contained 
within a typical 
CSF reservoir's 
volume (34 mm 
diameter and 
7.2mm height) for 
suitable 
implantation below 
the scalp, yet 
above the skull, 
with pressure 
communication 
through a cranial 
burr hole. 
R3.0 The sensor 
must provide 
clinically 
acceptable 
ICP 
resolution 
and 
accuracy. 
  
→ 
O3.1 Sensor must 
provide a pressure 
range from -500 
mm H2O to +500 
mm H2O. 
    
→ 
O3.2 Sensor must 
provide a 10 mm 
H2O resolution, or 
less, up to 200 mm 
H2O and within a 
10% maximum 
beyond. 
    
→ 
O3.3 Sensor must 
provide a 
maximum accuracy 
(or trueness) of ±5 
mm H2O. 
    
→ 
O3.4 Sensor must 
provide a 
maximum precision 
of ±5 mm H2O. 
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Table 2 (continued) 
Top Level 
Requirements 
Key Requirements for 
Sensor Element(s) Research Objectives 
  
  
→ 
O3.5 The sensor must 
overall provide a 
combined 
maximum accuracy 
(incl. precision) of 
±10 mm H2O.over 
a ±200 mm H2O 
range and 10% 
maximum beyond. 
R4.0 The sensing 
mechanism 
must support 
non-invasive 
readout. 
R4.1 The sensor and/or 
supporting 
electronics must 
provide a 
compatible 
electrical signal for 
non-invasive 
transcutaneous 
transmission. 
O4.1 Buffered sensor 
output must be 
capable of 
providing a signal 
within a 0 - 3.3 volt 
range for 
interfacing to the 
Texas Instruments 
CC2541 ADC and 
Bluetooth LE 
system-on-chip. 
    R4.2 The sensor and 
associated 
transponder 
electronics must not 
exceed a power 
consumption limit 
necessary to 
operate over a ten-
year service life or 
that exceeds a safe 
level for 
transcutaneous 
powering. 
O4.2 The estimated 
power consumption 
of the sensor's 
transponder must 
be less than that 
which can be 
transcutaneously 
transmitted safely 
per IEEE Standard 
for Safety Levels 
with 
Respect to Human 
Exposure to Radio 
Frequency 
Electromagnetic 
Fields, C95.1.  
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Table 2 (continued) 
Top Level 
Requirements 
Key Requirements for 
Sensor Element(s) Research Objectives 
    R4.3 The sensor must be 
capable of non-
invasive post-
implant calibration 
(or otherwise 
maintain acceptable 
accuracy and 
precision as 
specified). 
O4.3 The sensor must 
be capable of gain 
and offset 
calibration to meet 
the specified 
accuracy. 
R5.0 The sensor 
must support 
a ten-year 
service life. 
R5.1 Drift performance 
must be sufficient 
for indicating shunt 
failure or for 
distinguishing 
dangerous ICP 
values.   
O5.1 Expected drift over 
the device's 
intended service 
life must be less 
than ±50 mm H2O. 
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demonstrated that ICP microstrain sensing resulted in the lowest drift 
measurements over time and temperature, notwithstanding the manometer, 
compared to fiber optic and capacitive means.  Distal fiber optic transduction 
lacks temperature compensation methods, and when calibrated ex-vivo without 
temperature-based zeroing, the technique easily results in thermally related 
pressure shifts in-vivo.  Capacitive based sensors for low pressure liquid media 
sensing have shown low sensitivity, such as that by George et. al.  Sensitivity 
levels have been reported to demonstrate atto-farads per mm H2O, which 
necessitates on-chip processing electronics to minimize parasitic capacitance.  
Further, the literature reports capacitive based sensing is subject to drift resulting 
from biomatter adsorption onto the sensor’s plates and non-condensing moisture 
intrusion [72, 88, 100].  Microstrain sensing, however, has a proven history of 
acceptable clinical use for ICP, short of long-term drift, providing a proven 
biocompatible interface for CSF and brain tissue.  Barlian et al. found that 
piezoresistive sensing provided distinct advantages over capacitive sensing 
including ease of differential configurations and freedom from film stress related 
errors and surface micromachining yield challenges [101].  In consideration 
toward accomplishing the goal of this work, microstrain sensing will be chosen as 
a potential solution.   
Metallic Strain Sensing 
Microstrain pressure sensors are based upon measuring the strain incurred by 
the deflection of a pressure diaphragm.  The shape of the diaphragm is arbitrary, 
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but usually takes the form of a circle or square.  Metal diaphragms were originally 
employed, continuing into the 1970’s, with strain gauges bonded thereupon by 
epoxies, phenolics, or eutectics [102].  Popular to early applications, and prior to 
piezoresistive sensors, strain was quantified by measuring the conductivity of a 
resistive metallic foil pattern joined to the diaphragm substrate.  Figure 10 
illustrates an example resistive pattern in which two electrical terminals are 
provided to the left of the figure, which are connected to an interwoven 
conductive design.  The resistivity of the segments is given by Ohm’s law: 
𝑅 ൌ 𝜌 𝑙𝐴 
where ρ is the specific electrical resistance of the metal, l is the length, and A is 
the conductor’s cross-sectional area.  When lateral forces (i.e. horizontal to the 
page) extend the design, the interwoven conductive lines become elongated, 
increasing the length of each resistive segment and correspondingly decreasing 
the cross-sectional area, which altogether increases resistance.  Alternatively, 
when lateral forces compress the design, the resistive lines broaden and shorten, 
thereby decreasing resistance [103].  The serpentine layout serves to increase 
the gain of the sensor since stress applied to the sensor not only affects one 
resistive segment, but multiple parallel segments in series over a relatively small 
sensing area.  
 
 62 
 
Figure 10 – Conventional metallic micro-strain resistive pattern. 
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The gauge factor is essentially the gain of the device providing the change in 
resistance for an applied stress resulting in strain.  The gauge factor is defined 
as: 
𝐺𝐹 ൌ
𝜕𝜌
𝜌
𝜀  
where ε is the applied strain to the device. 
Piezoresistive Strain Sensing 
In 1954, Charles Smith observed and described the piezoresistive effect in silicon 
and germanium semiconductors, providing a change in resistance upon applied 
stress [104].  The piezoresistive effect for n-type silicon was thereafter further 
described by Herring's theory of the many-valley conduction/valence-band model 
[105].The model explained that crystal lattice strain disperses carriers across 
several valleys (up to six in silicon aligned with three <100> directions), which 
perturbs the longitudinal and transverse average mass.  Compared to the 
unstressed lattice, this leads to an isotropic overall effective mass, m*.  Strain is 
theorized to alter the energy band curves to effectively change the mass and, 
hence, the conductivity.  Depending upon whether carriers are dispersed to lower 
or higher conduction states, changes in effective mass will result in either a 
decrease or increase in resistivity.  The mechanism of the p-type piezoresistive 
effect has largely remained uncertain, until recently, due to the complexity of its 
valence band structure.  However, recent theoretical approaches attribute the 
effect to a similar mass change from band warping and splitting [101]. 
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The piezoresistive coefficient relates the fractional change in resistance to the 
applied stress.  The coefficients, π, necessitate four subscripts since they relate 
two second-rank tensors, stress and resistivity.  The first subscript refers to the 
direction of voltage measurement, the second to current flow, and the third and 
fourth to orthogonal stress components.  However, in the most common case, 
where the direction of current flow and applied stress may be parallel or 
perpendicular to each other, and oriented in the <100> or <110> crystalline 
lattice directions, the net change in resistivity may be written as the sum of the 
parallel and perpendicular effects.  As such, a diffused resistor subjected to 
parallel and perpendicular stress components σ‖ and σ┴, respectively, the 
resistance change is given by:  
∆𝑅
𝑅 ൌ π‖σ‖ ൅ π┴σ┴ 
where π‖ and π┴ are the piezoresistive coefficients parallel and perpendicular to 
the resistor length.  It can be shown that the piezoresistive coefficients π‖ and π┴ 
can be derived for any arbitrary crystalline direction from the π11 (typical of n-
type), π12, or π44 (typical of p-type) [101, 106].  The advantage of piezoresistors 
over conventional metallic strain sensors, other than direct implantation, is that 
the gauge factor can be 50 – 100 times larger, or more [107, 108].  The 
magnitude of the piezoresistive effect varies with crystal orientation of the 
resistor. In order to maximize sensitivity piezoresistors are typically oriented in 
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the <100> direction for n-type doping and <110> direction for p-type doping [106, 
107]. 
The first commercial devices were introduced in 1958 with early applications 
primarily targeted toward biomedical and aerospace applications [102].  The 
development of silicon and germanium piezoresistive strain sensors facilitated 
pressure sensors with either strain sensors applied upon a sensing diaphragm or 
within the diaphragm itself.  Pressure sensing diaphragms with strain sensing 
elements applied thereupon suffered from poor stability arising from factors such 
as thermal mismatch and adhesive creep [102].  Single crystalline diaphragms 
with diffused piezoresistors quickly disrupted the former market providing 
superior diaphragm properties negating hysteresis and creep formerly found in 
metal diaphragms.  For thin silicon or germanium diaphragms with small 
defections, the resistance change is linear with applied pressure, being perfectly 
elastic at temperatures less than 500°C.  Higher volume, lower cost applications 
thereafter quickly followed. 
Pressure Transduction 
Pressure transducers utilizing a diaphragm with strain gauges typically employ 
four strain sensors forming a Wheatstone bridge [109].  The Wheatstone bridge 
configuration has been shown to be the optimal configuration for minimal 
detectable pressure signals in a diaphragm [110].  The diaphragm is usually 
designed such that two strain sensors increase in resistance upon incident 
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pressure, while the other two sensors decrease in resistance, thereby increasing 
the gain of the overall transducer.   
Figure 11 illustrates an electrical schematic of a pressure transducer’s resistive 
strain sensors arrangement into a Wheatstone bridge.  Strain sensors designated 
by R1 and R3 decrease resistance upon positive incident pressure to the 
transducer’s diaphragm.  R2 and R4, however, increase resistance and 
therefore, in combination with R1 and R3, improve the sensitivity of the 
transducer.  In this configuration, the optimal piezoresistive diaphragm would be 
one that produces relatively high stress levels in response to incident pressure, a 
large delta between longitudinal and transverse stress, and relatively small 
spatial stress gradients over the piezoresistor implant locations [106].  From 
Figure 11, by letting Vo = +Vo – (-Vo) and a supply voltage of Vs = +V – (-V), it 
can be formulated from the schematic that: 
𝑉௢ ൌ 𝑉ௌ ൬ 𝑅ଶ𝑅ଵ ൅ 𝑅ଶ െ
𝑅ଷ
𝑅ଷ ൅ 𝑅ସ൰ 
The output voltage is zero when the bridge is in balance according to the 
condition: 
𝑅ଵ
𝑅ଶ ൌ
𝑅ଷ
𝑅ସ 
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Figure 11 – Wheatstone pressure transducer comprising strain sensors. 
A change in resistance for each of the four strain sensors results in: 
𝑉௢ ൌ 𝑉ௌ ൬ 𝑅ଶ ൅ 𝛥𝑅ଶ𝑅ଵ ൅ 𝛥𝑅ଵ ൅ 𝑅ଶ ൅ 𝛥𝑅ଶ െ
𝑅ଷ ൅ 𝛥𝑅ଷ
𝑅ଷ ൅ 𝛥𝑅ଷ ൅ 𝑅ସ ൅ 𝛥𝑅ସ൰ 
If R1 = R2 and R3 = R4 then expanding the equation above and substituting 
provides: 
𝑉௢ ൌ 𝑉ௌ ቆ𝑅ଵሺ𝛥𝑅ଷ ൅ 𝛥𝑅ସሻ െ 𝑅ଷሺ𝛥𝑅ଵ ൅ 𝛥𝑅ଶሻ ൅ 2𝑅ଷ𝛥𝑅ଵ െ 2𝑅ଵ𝛥𝑅ସ4𝑅ଵ𝑅ଷ ൅ 2𝑅ଵ𝛥𝑅ଷ ൅ 2𝑅ଵ𝛥𝑅ସ ൅ 2𝑅ଷ𝛥𝑅ଵ ൅ 2𝑅ଷ𝛥𝑅ଶ ቇ 
By making an assumption that ΔR/R << 1 and that Rx•ΔRy << Rx•Ry, then the 
expression above can be shown [111], with corrections, to simplify to: 
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𝑉௢
𝑉ௌ ൌ
1
4 ൬
𝛥𝑅ଵ
𝑅ଵ െ
𝛥𝑅ଶ
𝑅ଶ ൅
𝛥𝑅ଷ
𝑅ଷ െ
𝛥𝑅ସ
𝑅ସ ൰ 
and by utilizing the gauge factor, GF, the expression further simplifies to: 
𝑉௢
𝑉ௌ ൌ
𝐺𝐹
4 ሺ𝜀ଵ െ 𝜀ଶ ൅ 𝜀ଷ െ 𝜀ସሻ 
Therefore, this simplified derivation relies upon two important points:  that the two 
bridge leg resistances are equal, and that R is quite large such that ΔR/R is very 
small.  Furthermore, in order to negate offset and temperature effects, it is 
preferable that all four bridge resistances be equal [103]. 
Modern micro-electro-mechanical systems (MEMS) commonly provide monolithic 
piezoresistive implanted pressure diaphragms fabricated using micromachining 
etchants.  Prevalent pressure sensor types include both bulk micromachined 
monocrystalline silicon as well as surface micromachined polysilicon employing 
thin-film depositions.  There are additionally some pressure sensors which are 
fabricated from bonded metal foil.  Monocrystalline silicon material possesses 
excellent mechanical qualities described by Petersen encompassing high 
strength, high stiffness, high reliability, high Q, high precision, and with low 
mechanical hysteresis [112, 113].  Surface micromachined materials, however, 
do not possess the same high-quality properties.  They are usually comprised of 
polycrystalline or amorphous thin films with existing material stress or 
unfavorable energies [102].  Nonetheless, the advantage of thin-film deposition 
lies within the opportunity for CMOS integration using a two-step process first 
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leveraging mainstream CMOS fabrication with subsequent MEMS specific 
processing [113].  Contemporary MEMS technologies employ a variety of silicon 
including bulk silicon (Si), silicon on insulator (SOI), silicon on sapphire (SOS), 
and silicon carbide (SiC), as well as additional materials such as steel, carbon 
nanotubes (CNT), and even diamond for critical rugged environments [114].  
Common MEMS pressure sensor fabrication techniques encompass isotropic 
and anisotropic etching, diffused or ion implanted resistors, and various forms of 
bonding ranging from anodic to direct. 
TE Connectivity (previously Measurement Specialties) produces a range of 
MEMS pressure sensors, formerly offered in bare die, in both absolute and 
differential configurations.  The closest pressure range devices offered by TE 
Connectivity sought by this work are the 1620 and 1630, which utilizes 
piezoresistors, providing a -50 to 300 mmHg (-680 to 4,079 mm H2O) range.  
Figure 12 shows the 1630 and its cross-sectional diagram.   
Sensitivity of the devices are specified at 368 nV/V/mm H2O.  The 1630 device is 
marketed for use as a biocompatible and temporarily implantable pressure 
sensor, favorably offering connections on one side of its ceramic substrate.  The 
sensor utilizes film resistors on the printed circuit board (PCB) substrate allowing 
laser trimmed temperature compensation.  Input resistance is specified between 
1.2kΩ and 3.2kΩ with output resistance between 270Ω and 330Ω.  For liquid 
media compatibility, a dielectric silicone gel is provided over the topside of the die 
for fluid isolation.  The life of the device is limited to 72 hours.  The company also 
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Figure 12 - TE Connectivity 1630 
(Source: TE Connectivity)  
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offers several 0 – 1 PSI sensors.  However, TE Connectivity does not offer any 
matched die configurations, which will later be shown imperative, nor bipolar 
devices in the desired pressure ranges.  The operating pressure range of the 
16** series is greater than 8x the desired range of this work’s goals, thereby 
likely diminishing desired resolution. 
The Sensor Technology Group of Amphenol produces biocompatible pressure 
transducers based upon bulk micromachined monocrystalline piezoresistive 
sensors.  The sensors are marketed for low drift performance utilizing what the 
manufacturer markets as trade secret construction that alleviates long term 
mechanical creep.  Very important to this research, as will be explained 
hereafter, is that Amphenol produces matched die configurations.  Their All 
Sensors millivolt series, being passive only, allows for customized voltage bias, 
which is desirable for low voltage operation to reduce quiescent power conditions 
in the transponder design as well as ease requirements of telemetry power 
transfer.   
Various ranges are offered by Amphenol within the span of several inches of 
water pressure.  The 30 INCH-D-MV operates within the ±30 inches H2O (i.e. 762 
mm H2O) and has a corresponding full-scale output signal between 19 and 21 
mV with 20 mV typical at 12V bias (i.e. 2.19 µV/V/mm H2O).  The sensor module 
is marketed for use with non-condensing gases, likely due to both top-side and 
bottom-side die fluid contact.  However, for this research, only bottom-side die 
will be used for liquid media contact.  Amphenol specifies the sensor for long 
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term drift of ±100µV over a one-year time period.  Translated over the full-scale 
range of the device, this figure suggests an expected drift of ±3.8 mm H2O per 
year.  The device is temperature compensated with laser trimmed resistors and 
can be parylene coated, offering an additional and optional biocompatible 
interface with excellent moisture and chemical barrier properties [115].  
Specifications indicate the bridge resistance (i.e. input) for its combined dual 
sensor configuration is 4.5kΩ with an output of 1.5kΩ, which as shown later, 
results in an average of 1.5kΩ per piezoresistor.  Compared to TE Connectivity, 
this sensor utilizes a higher strain resistance, which improves linearity as shown 
within the bridge derivation above whereby a ΔR/R << 1 results in the output 
essentially becoming a product of the strain, ϵ, and gauge factor, GF.  Further, 
when compared with TE Connectivity, the 30 INCH-D-MV provides larger gain at 
2.19 µV/V/mm H2O since the sensor’s span is 762 mm H2O versus the 
unnecessary large range of the TE Connectivity 1620/30 (4,079 mm H2O) at 
0.368 µV/V/mm H2O, resulting in a 6x improvement.  The 30 INCH-D-MV 
provides a sufficient proof pressure of 5,080 mm H2O, which is well beyond 
physiological ICP pressures or normal atmospheric variations.  Burst pressure is 
specified at greater than 20,000 mm H2O.  Finally, Amphenol is the only 
manufacturer to specify low pressure long-term drift values in which the values 
may be acceptable for ICP monitoring if indeed proven with liquid media.Figure 
13 shows a microphotograph of one of the 30 INCH-D-MV Amphenol dies. The 
silicon die is a monocrystalline bulk micromachined pressure sensor utilizing  
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Figure 13 – Amphenol All Sensors 30 INCH-D-MV pressure sensor die, 
approximately 2 mm2. 
(Source: All Sensors Corporation) 
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a square diaphragm.  The diaphragm is specialized in that it consists of two 
monocrystalline monolithic layers, being etched top-side and bottom-side to 
result in a sensitive stress concentrated design.  The process is proprietary and 
partially described in Sensym’s U.S. Patent 5,178,016 as a sculptured diaphragm 
[116].   
Piezoresistors are implanted in locations of the thick upper relief shelf, forming a 
Wheatstone bridge.  The custom diaphragm increases bending moment at the 
location of its shear sensing elements through the load of its thin portion of the 
diaphragm, which is suspended by the periphery and thicker relief elements.  
Thinner diaphragms enhance sensitivity whereas thicker diaphragms improve 
linearity due to lower deflections, consistent with small deflection theory [114].  
Unlike other silicon piezoresistive sensors, the Amphenol device does not utilize 
a surrounding boss structure.  Bossed structures increasingly suffer from position 
sensitivity arising from the acceleration of gravity’s influence upon the very 
sensitive diaphragm’s mass necessary for low pressure sensing. 
The Amphenol die employs six implanted resistors within its upper relief.  As 
shown in Figure 13, the center horizontal thick relief pair (dark color) contains two 
resistors beginning at the left edge of the diaphragm, which are connected in 
series.  In the center, are two more piezoresistors, which are additionally 
connected to another set of series resistors at the right edge, forming a 
Wheatstone bridge.  Note, in Figure 13 the lower-left arm of the thicker relief is a 
split circuit for ground, or negative connections to the die.  This split circuit 
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divides the Wheatstone bridge into two, allowing better balancing and zeroing of 
the device.  Figure 14 shows a microphotograph side view of the 30 INCH-D-MV 
sensor.  The sensor’s silicon support structure, which contains a bottom-side 
machined cylindrical orifice, is bonded to its ceramic PCB substrate with a white 
adhesive.  The adhesive is likely comprised of a low-stress silicone acting as a 
buffer against thermal mismatches between the two materials.  Other 
biopressure sensors in the literature have used Corning RTV 3140 silicone, for 
example, which has demonstrated minimal thermal mismatch stresses with 
silicon [117]. 
Thereupon the silicon support structure is the pressure sensor’s monocrystalline 
silicon die with an upper single crystal epitaxial layer.  The intermediate diffused 
marking is a tooling artifact and not present on all sides of the die.  The 
fabrication process is described by Dauenhauer (the manufacturer’s co-founder 
and co-inventor of CoBeam2 technology) and Reimann in U.S. Patent 5,178,016 
Figure 8, in which the sensor’s diaphragm thickness is approximately that of the 
epitaxial layer [116].  Further described within the patent is the sculptured 
diaphragm’s upper relief containing a 3,000 Angstrom thick chromium metal layer 
formed by sputter deposition.  Figure 15 shows the wire bonded die mounted on 
its ceramic PCB substrate secured and sealed by the white flexible adhesive.  
The bottom of the PCB provides an orifice for fluid communication to the die’s 
opposite/bottom side diaphragm.  Figure 16 shows nearby film resistors, having 
been laser trimmed (horizontal score mark) for precise balancing of the bridge. 
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Figure 14 – 30 INCH-D-MV side view at 40X (photo border provided for clarity). 
 
 
Figure 15 - Amphenol sensor die deployment upon ceramic PCB with 
soldermask. 
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Figure 16 – Laser trimmed film compensation resistors. 
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As shown in Figure 13 and Figure 15, the Amphenol die is anisotropically etched 
to produce a square diaphragm.  Clark and Wise derived the governing 
electromechanical equations for rectangular thin diaphragm silicon pressure 
sensors using finite difference numerical methods [106].  The analysis revealed a 
50% improved sensitivity for square diaphragms over circular implementations of 
the same dimensions (i.e. square length equal to circular diameter). 
Piezoresistive characteristics are key for maximizing sensitivity, including 
location, physical size, conductivity and type, orientation, doping levels, and 
temperature [101, 106, 118].  Under load, stress is highest along the periphery of 
the diaphragm, both for rectangular and circular diaphragms.  Stress, as a 
function of position from center-to-edge, begins to gradually increase at the point 
approximately two-thirds radial distance from the center.  Beyond two-thirds 
distance from the center, stress rapidly increases to a maximum at the edge, 
where resistor placement is most sensitive [106].  Implanted piezoresistors 
average stress over their geometry and for the Wheatstone bridge, maximum 
pressure sensitivity is achieved using two parallel and two perpendicular resistors 
in the <110> direction [68].  Accordingly, the diaphragm is oriented in the <110> 
direction.   
The physical size of piezoresistors presents a trade-off between reproducibility, 
which increases with size, and pressure sensitivity as resistor size decreases.  
From Figure 13 it can be seen that the Amphenol edge resistors, implanted 
within the upper relief’s moment arm, are physically placed parallel to each other, 
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yet in series by virtue of the adjoining edge metal.  This arrangement maximizes 
sensitivity of the edge piezoresistors to capitalize on the stress presented by the 
diaphragm’s edge by implanting dual short resistors.  The two resistors increase 
resistance in series and, hence, maximize the gauge factor and gain of the 
sensor. 
The sensor manufacturer specifies an input impedance of 4.5kΩ and an output 
impedance of 1.5kΩ for the sensor module, which incorporates two identical dies 
connected in parallel.  Therefore, the equivalent individual die input resistance 
can be deduced to 9 kΩ with an output resistance 3 kΩ for each die.  It can be 
derived that for a balanced bridge circuit, with equal bridge resistors and equal 
span resistors, the input resistance is given by any bridge leg piezoresistor plus 
twice the resistance of either span resistor [119].  The output resistance is simply 
the value of any bridge leg piezoresistor.   
Amphenol provides a schematic representation of the bridge circuit with span 
resistors for temperature and offset compensation on the power supply inputs.  
These resistors are actually located on a separate printed circuit board located in 
close proximity to the sensor die.  Taking into account the series connected edge 
piezoresistors, the actual die effectively consists of four overall bridge resistors.   
The Amphenol sensor specifications indicate a typical settling time of 100 µsec or 
less for 10 to 90% signal.  Consequently, a delayed sampling, either during 
testing/evaluation or in actual deployment, will be necessary to prevent an ADC 
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conversion from occurring while the sensor is still yet settling from power up.  In 
an effort to minimize any error induced by sampling the sensor’s output signal, it 
is desirable to understand the settling time of the sensor to less than 1% error.  
The 10 to 90% rise time of a single time constant circuit is approximately: 
𝑡௥௜௦௘ ≅ 2.2𝜏 
Since the sensor manufacturer specifies a 100 µsec 10 to 90% rise time, a single 
time constant estimation was calculated.  Substituting into the equation results in 
a τ of 45 µsec.  For less than a 1% settling, more than four exponential time 
constants are required and therefore, five was chosen in order to arrive at a 
metric necessary for a delay circuit.  Five-time constants results in a delay of 227 
µsec. 
Since a single-time constant circuit can be configured from an equivalent resistor 
and capacitor network, a capacitor value can be derived from the single time 
constant equation of 100 µsec = 2.2•1.5kΩ•C, where C equates to 30.3 nF.  
Decoupling the dies from parallel to independent sensors, the equivalent 
capacitance for each die is 15.15 nF with an output resistance of 3kΩ.  
Therefore, the single-pole bandwidth of each sensor die is approximately 3.5 
kHz.  The manufacturer’s model of the sensor is shown in Figure 17, while the 
actual individual die’s bridge model is shown in Figure 18.  
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Figure 17 – Amphenol published equivalent circuit. 
 
 
 
Figure 18 – Derived Wheatstone bridge pressure sensor model. 
  
 82 
All considered, the Amphenol 30 INCH-D-MV die was selected for further 
research and development within this work given the die possesses a sensitivity 
of 2.19 µV/V/mm H2O, a span of ±762 mmH2O, variable low voltage operation, 
and parylene biocompatibility in an area of approximately 2 mm2.  Very 
importantly, Amphenol can produce matched die components.  With regard to 
resolution, the sensor is specified with a linearity and/or hysteresis error of 0.05% 
FSS, which equates to 0.38 mm H2O.  Complete specifications of the device are 
provided within the Appendix.   
Sensor System Design 
Koskinen’s research found that the Codman microstrain device demonstrated low 
pressure drift, deemed clinically acceptable, whereas Piper concluded the 
opposite regarding the Camino fiber optic system.  Although microstrain devices 
are indeed sensitive to thermal effects, silicon based microstrain devices offer the 
opportunity for bandgap temperature compensation techniques or compensation 
via resistors with offsetting thermal coefficients which may further be precisely 
trimmed.  Considering the sensor system altogether, the consensus from the 
literature review is that microstrain devices present less drift in clinical 
deployments.  Therefore, this research will seek to advance upon these findings 
for microstrain devices by further developing and evaluating means for 
minimizing and/or mitigating residual inaccuracies within the sensing mechanism. 
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Cross-Coupled Dual-Die Single-Reference Pressure Sensor 
One such means for potentially reducing drift is by employing two piezoresistive 
pressure sensors on a common substrate, such as ceramic.  In such a 
configuration, two pressure sensors may be arranged to encounter mechanical 
stresses in common-mode and therefore negate, or offset, erroneous sensor 
read-out effects.  Such a system is described by Dauenhauer et. al. in U.S. 
Patent 6,023,978 as a pressure transducer with mechanically cross-coupled 
fluidic pressures stimulating two alternating sensor die faces with error 
compensation further comprising electrically cross-coupled outputs of the two 
sensors [120].  In this system, conceptually shown in Figure 19, one pressure 
acts as a reference pressure (e.g. atmospheric) and another is the unknown 
pressure under test.   
Figure 19 – Illustrative cross-section concept of dual pressure sensors with each 
P1 and P2 cross-coupled to top-side and bottom-side dies. 
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In the dual sensor configuration shown in Figure 19, the sensor dies are co-
located upon a common mounting substrate whereby stresses become common 
mode.  By virtue of the sensors’ cross coupled outputs, as shown in Figure 20, 
the total output signal becomes the superposition of the two sensors, subtracting 
out the common stress.  In order to do so, each sensor’s transfer function must 
be substantially identical to the other and therefore necessitates matched silicon 
dies.   
Performance matched sensors use die taken from the same silicon wafer, since 
error characteristics are predominately process related [120].  Sensor dies 
located within the same area of a wafer tend to have even further similar 
performance characteristics.  For matched sensor dies, two die are often 
selected which are adjacent to each other during wafer dicing.  Such dies 
typically share the same effects of equipment registration (or misregistration as 
the case may be), such as orientation for ion implantation and other localized 
effects, including etch rate characteristics (evaporation rates, temperature 
gradients, impurities, etch area exposure distribution, or loading, etc.).  Adjacent 
pressure sensor dies also typically possess substantially similar zero and gain 
coefficients with temperature, being largely controlled by impurity concentration 
of doped regions [121].  Selected dies are thereafter measured, and further 
sorted if necessary, to verify equivalent transfer functions, including gain, offset, 
and linearity over operating parameter ranges (e.g. pressure, temperature, bias, 
etc.).   
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Figure 20 – Cross coupled dual sensor configuration for error compensation. 
Matched sensors are of importance in large systems necessitating differential 
pressure measurements where sensors may not be co-located, otherwise 
allowing one differential sensor.  Additionally, matched sensors are important for 
systems, such as that described herein, designed to eliminate common mode 
interference. 
In the Dauenhauer dual sensor configuration the pressure sensors are deployed 
in differential pressure mode in which one sensor serves as a reference sensor 
(e.g. atmospheric) to the second, which receives the pressure to be measured.  
The technology was licensed by All Sensors Inc. from Honeywell Data 
Instruments and thereafter commercialized under the CoBeam2 brand, which 
was later acquired by Amphenol.  For implantable use, the device would require 
an absolute reference or reliable means of atmospheric sensing.  Providing either 
of these are challenging.  One potential method may consist of a gas chamber to 
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pressurize the reference port.  However, this essentially becomes an absolute 
pressure sensor, leaving the overall sensor configuration vulnerable to drift by 
gaseous diffusion and leakage.  An alternative option may integrate a large broad 
subcutaneous liquid bladder connected to the sensor’s reference port in order to 
normalize any parasitic pressure from localized tissue growth yet communicate 
atmospheric pressure on average.  However, for ICP measurements, CSF 
pressure is position dependent.  Therefore, such a reference bladder would 
produce one differential pressure in one position and yet another differential 
pressure in a second position due to a changing reference, rendering the true 
CSF pressure elusive. 
Independent Dual-Die Dual-Reference BioPressure Sensor 
One solution for obtaining the benefits of a matched dual-die pressure sensor 
configuration is to actually decouple the two sensors and provide a common 
absolute reference as shown in Figure 21.  In this configuration, the sensor 
system provides two matched pressure sensor dies with a common pressure 
reference, yet two independent sensors, as shown in Figure 22, for measuring a 
reference pressure and, separately and independently, cerebrospinal fluid.  
The specifications and deployment of the dual biopressure sensor are described 
in U.S. Patent 9,668,663 as a result of this research, with other patents pending.  
The design may utilize a ventricular catheter, or alternatively a parenchymal 
pressure bladder, for fluid communication with a brain’s ventricles as illustrated in 
Figure 23 [47].     
 87 
 
Figure 21 - Independent dual sensor with absolute reference configuration for 
error compensation. 
 
 
Figure 22  – Independent output dual sensors with common power/bias rails. 
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Figure 23 – Biopressure transponder deployment with ventricular catheter. 
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Figure 24 illustrates the alternative fluid bladder pressure transducer for 
parenchymal measurements, which may reduce dependency on flow or slit 
ventricle complications in sensing pressure.  The reference port would employ a 
peritoneal catheter, providing an a-priori saline column serving as a known 
position dependent pressure reference.  The peritoneal catheter’s ability to 
provide such a position dependent pressure reference, being a function of fluid 
density and length, has been well characterized.  Since the 1960’s, when 
ventriculoperitoneal shunting became standard practice in the U.S., siphoning 
began to be researched as a result of its undesirable impact for inadvertently 
activating shunt valves, resulting in dangerous CSF over drainage effects [96, 
122].  Ironically, this siphoning effect may be advantageously utilized as a 
predictable in-vivo pressure reference source.  Complications of peritoneal 
catheters are rather rare with the most common issues reported being abdominal 
pseudocyst or hepatic pseudocyst formation.  The incidence of these 
complications ranges in the literature from 1 – 4.5%.  However, these 
complications are thought to be associated with CSF shunt infections or from 
multiple abdominal surgeries [123].  In the case of the biopressure sensor’s use 
of the peritoneal catheter, specifically as a pressure reference, no CSF will be 
discharged, notwithstanding a separate peritoneal catheter for CSF shunting 
purposes.  The distal end of the sensor’s reference catheter is intended to be 
open, terminating into the peritoneum, subject to atmospheric pressure.  
Alternatively, the catheter may simply be implanted in the subcutaneous plane 
since no fluid drainage is intended to occur. 
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Figure 24 – Alternative transponder deployment with fluid bladder as a 
parenchyma pressure transducer. 
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Walker and Criddle’s research on the pathophysiology of abdominal 
compartment syndrome [124] found that the peritoneal cavity normally resides at 
atmospheric pressure, which was also reported by Drake [3].  The route of the 
peritoneal catheter, just subcutaneous, from head to abdomen, is also generally 
at atmospheric pressure, particularly when taken as the average over the 
catheter’s length.  In this configuration, as shown in Figure 25, the reference port 
pressure will be equal to atmospheric, or at a prescribed pressure near 
atmospheric depending upon routing, in a patient’s supine position and 
approximately -ρgh in the upright position.   
In considering each sensor independently and as an absolute pressure sensor 
with a common reference gas, physiological pressures would be in addition to a 
full range of possible barometric conditions.  Extreme ranges can span from 0.86 
atmospheres up to 1.06 atmospheres [125, 126, 127].  These pressures correlate 
to an absolute pressure sensor capable of 8,872 mm H2O on the low end up to 
11,472 mm H2O for the highest recorded atmospheric pressure including 500 mm 
H2O.  However, as will be later shown, appropriate configuration of the dual 
pressure sensor’s common absolute reference under typical conditions (e.g. the 
mean) results in an acceptable response. 
Given the sensor outputs are independent, the gain of the reference sensor can 
be determined by reading the absolute pressure of the reference column in two 
patient positions (e.g. supine, or 0°, and upright, or 90°) as follows: 
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Figure 25 – System deployment of biopressure sensor with reference fluid 
column and shunt integration (shunt peritoneal catheter shown). 
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Next, for offset correction, since the reference port is subject to atmospheric 
pressure and the sensor is read-out in absolute mode, the output will equal the 
barometric pressure with the patient in the supine position (or barometric less 
ρgh•cos(θ) in any other position).  With a known input pressure (i.e. barometric) 
being accurately measured ex-vivo via a calibrated barometer, a sensor offset 
can be derived as follows: 
 
* where Patm is measured ex-vivo via a calibrated barometer. 
Utilizing matched sensor dies enables the corresponding CSF sensor’s gain and 
offset values to be determined via the reference sensor.  Therefore, once the 
system undergoes calibration by means of its reference sensor and peritoneal 
catheter reference, accurate CSF measurements may be obtained which are 
compensated for gain and offset drift by: 
 
Deployment and Implantation  
Figure 23 illustrates the general approach of the transponder and its sensors for 
human implantation, which in the embodiment shown, an integrated shunt is 
𝑚 ൌ 𝑣ଵሺ90˚ሻ െ 𝑣ଵሺ0˚ሻ൫𝑃௔௧௠ ൅ 𝑃௖௢௟ሺ90˚ሻ െ ሺ𝑃௔௧௠ ൅ 𝑃௖௢௟ሺ0˚ሻ൯ 
𝑏 ൌ 𝑣௉ೌ ೟೘ െ ൫𝑃௔௧௠ ൅ 𝑃௖௢௟ሺ𝜃ሻ൯ ∙ 𝑚 
𝑃௖௦௙ሺ𝜃ሻ ൌ 𝑣ଶ െ 𝑏𝑚 െ 𝑃௔௧௠ 
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provided.  As indicated within the literature, ventricular cannulation remains the 
“gold standard” of ICP measurement.  Hydrocephalus patients who undergo 
ventriculoperitoneal shunting possess ventricular catheters often infection free for 
years. Therefore, this design will incorporate a subcutaneous pressure 
transducer implanted just underneath the scalp, connected to a ventricular 
catheter, or alternatively a parenchymal bladder.   
Figure 23 shows a right-angle connection to the ventricular catheter which also 
facilitates shunt flow of CSF to its terminal site (e.g. the peritoneum, pleura, or 
atrium).  These types of catheters are typically of one-millimeter inner diameter 
Silastic® (i.e. silicone) with a hardness commonly around 65 Shore A.  Due to the 
soft material, they may remain compliant, even when occluded, and, in a closed 
pressure system, may partially transmit ICP to the transponder.  Ventricular 
cannulation also allows for the transponder’s implant site to be remote, just under 
the subcutaneous plane of the scalp, for improved telemetry coupling compared 
to a deep implant. 
Additionally, shown in Figure 23 is the transponder’s reference fluid column 
comprising a saline solution.  The reference lumen connects to the transponder’s 
Reference Sensor #1, as shown in Figure 21, to provide a position dependent 
pre-known pressure reference.  The transponder is anticipated to be titanium 
construction utilizing glass-to-metal seals for integrating the telemetry antennas, 
which are external to the transponder housing, yet subcutaneous.  The 
transponder’s signal antenna will carry the pressure signal while a second 
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antenna will facilitate inductive power coupling.  Although the design, given its 
subcutaneous placement, could possibly utilize optical coupling, hair upon the 
scalp could significantly impede such an approach.  Therefore, this design will be 
slated for electromagnetic telemetry for both power, via inductive coupling, and 
high-frequency near-field pressure readout communications.  The transponder 
may therefore be entirely passive without any internal power source. 
Supporting non-invasive readout of pressure, the transponder may utilize 
Bluetooth LE for low-power digital communications.  Bluetooth LE is compatible 
with modern smartphones and thereby facilitates easy readout on readily 
available multipurpose devices.  Several smartphones, including the iPhone 6 or 
later, include a barometric sensor, which may be utilized for offset correction.  
Figure 26 provides a block diagram of the transponder’s electronics whereby the 
pressure sensor is amplified by a low power instrumentation amplifier (IA).  The 
IA output is fed into a Texas Instruments microcontroller’s analog input.  The 
CC2541 integrates a Bluetooth LE transceiver and Bluetooth software stack.  
Separately, the Texas Instruments BQ500210 and ST Microelectronics 
STWLC04 chipset provides a telemetry control unit and receiver for 
transcutaneous inductive powering of the transponder.  The ST Microelectronics 
STWLC04 is optimized for 1W power transfer providing an approximate 60% 
efficiency, thereby lowering the required transcutaneous energy transfer versus 
other receivers. 
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Figure 26 – Transponder and readout deployment block diagram. 
(research focus outlined in blue dotted line) 
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Electronics Readout Overview 
Readout of the ICP pressure sensors, described in prior sections, is comprised of 
a two-part assembly.  The first encompasses the ex-vivo powering and 
demodulating unit for physician or patient use and interpretation.  This 
functionality may take advantage of smartphone integration utilizing a Bluetooth 
LE enabled device to provide communication and a user interface while a second 
module transcutaneously powers the transponder.  The second part of the 
system consists of the implantable pressure transponder, which contains the dual 
biopressure sensor and receives power from the first system, responding with a 
Bluetooth LE encoded pressure signal.  The transponder’s pressure sensor(s), 
and specifically its limitations of accuracy, are the object of research within this 
work. 
Figure 26 lays out the general approach of the pressure transponder and readout 
mechanism.  The front-end analog electronics consists of an instrumentation 
amplifier which then supplies an amplified analog representation of pressure to 
the analog-to-digital converter (ADC) of the microcontroller.   Amplification of the 
sensor’s low voltage signal is necessary to produce an adequate signal-to-noise 
ratio with a low output impedance voltage driver for the ADC.   
Each sensor’s output is a differential signal generated by the Wheatstone bridge 
strain gauge supplying an amplifier with a very high input impedance which 
minimizes input loading effects.  Since the sensor’s output signal is 2.19 
µV/V/mm H2O, a high gain is needed very close to the sensor in order to boost 
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an unadulterated sensor signal above the noise floor present within the 
remainder of the transponder’s circuit.  Since the pressure sensor is intended to 
operate within a relatively stable pressure environment and with a sample and 
read approach, a low bandwidth analog channel is all that is required, which 
helps reduce power and noise.  With these considerations in mind, an 
operational amplifier topology was evaluated in a differential mode.  Figure 27 
shows the topology of an operational amplifier differential configuration.  The gain 
of the amplifier, for Rf = Rg and R1 = R2, is given by: 
𝑣௢
𝑣ଵ െ 𝑣ଶ ൌ െ
𝑅௙
𝑅ଵ 
 
Figure 27 – Operational amplifier differential configuration. 
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and the input impedance is: 
𝑅ௗ௜௙௙ ൌ 𝑅ଵ ൅ 𝑅ଶ 
Since this design is seeking a very high input impedance, as well as a high gain, 
it can be seen that in order to have a high gain with a high input impedance, Rf 
would quickly become extraordinarily large.  A large resistance can be 
challenging to control and in the deployment of an implantable transponder, such 
a large resistance determining the gain could become detrimental when 
considering any possible moisture intrusion that may affect its value. 
An alternative approach to buffering the sensor’s differential signal is the use of 
an instrumentation amplifier as shown in Figure 28.  For a CMOS or JFET 
instrumentation amplifier, the input impedance looking into the non-inverting 
inputs are nearly infinite with extremely low bias currents and therefore the gain 
of the amplification stage is independent of the input signal’s impedance.  The 
second stage of the instrumentation amplifier is simply the differential amplifier of 
Figure 27.  The gain of the instrumentation amplifier can be shown [103] to be: 
𝑣௢௨௧
𝑣ଵ െ 𝑣ଶ ൌ െ
𝑅ଷ
𝑅ଶ ቆ1 ൅
2𝑅ଵ
𝑅௚௔௜௡ቇ 
Therefore, the gain of the amplifier can be adjusted by one resistor, which is 
typically external for instrumentation amplifier integrated circuits (IC).  In addition 
to very high input impedances and a topology allowing high gains, it can also be 
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Figure 28 – Instrumentation amplifier. 
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shown [103] that the instrumentation amplifier possesses very high common-
mode rejection (i.e. ≥ 100 dB typically) in cases where the amplifiers gain 
resistors are very well matched, as is typically the case in modern ICs.  An 
additional benefit of the instrumentation amplifier is the node presented by R3, 
whereby a ground connection can be substituted with an offsetting reference.  
This feature is attractive for allowing low voltage operation of the transponder 
whereby bipolar operation of the pressure sensor can be achieved using only a 
positive power supply by establishing an offset ground/common node (e.g. at 
2.5V).  The downside of the instrumentation amplifier is that it can be more power 
consuming and potentially more expensive. 
A search was conducted for a low power, low offset voltage instrumentation 
amplifier with a high gain potential to mitigate the transponder’s typical noise 
floor.  Table 3 shows a narrowed selection of instrumentation amplifiers from 
Texas Instruments (TI) and Analog Devices (AD).  The selection was narrowed 
based upon low power and then evaluated for other requirements.  Although the 
INA-126 offers the lowest quiescent current of all considered, it also presents 
highest noise figure and least immunity.  The INA-141 was used in prior 
biopressure sensor research due to its low noise figure, high CMRR, and very 
low offset voltage and was further used in long-term testing later described [128].  
However, the AD8222 was discovered to further offer higher performance in each 
of these categories, only sacrificing maximum power supply at 18V versus 36V  
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Table 3 - Low power instrumentation amplifiers. 
 TI INA126 TI INA141 TI INA129-EP AD 8222  
Vcc (max) 36 36 36 18  V 
Vcc (min) 2.7 4.5 4.5 2.3  V 
Input Bias Current 25 5 5 1  nA 
Input Offset 3.0 0.5 0.5 0.3 μV/°C 
Noise @ 1kHz 35 8 8 8  nV/rt(Hz) 
CMRR 83 117 120 126  dB 
Non-Linearity (max) 0.002 0.002 0.002 0.002  % 
Bandwidth @A=100 9 200 200 140  kHz 
Quiescent Current, Iq 0.175 0.750 0.700 1.000  mA 
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and bandwidth at 140 kHz versus 200 kHz, of which neither parameter was 
unacceptable for the sensor application.   
Methods 
This section describes the methods for simulation and evaluation of the new 
sensor design described within the Approach.  Of key interest is the evaluation of 
drift mechanisms and any mitigating results of the new sensor and its calibration 
method.  This section outlines the methods for verifying the requirements and 
objectives given by Table 2. 
Simulation 
As referenced in the Sensor Technology section of the Approach, in order to 
negate the sensor’s offset and piezoresistor temperature response, all four 
bridge piezoresistors must be near equal.  While ratio matching of diffused 
piezoresistors is quite good relative to absolute tolerancing, it is nevertheless 
imperfect.  Based on the literature review, regional brain temperature gradients of 
0.4°C were found extending from the brain’s surface to the ventricles.  
Additionally, temperature variations of 0.2°C were measured over the circadian 
cycle.  Although small, the effect of these variations must be evaluated with 
respect to the sensor’s pressure transduction.  To examine any potential impact 
upon offset or from temperature swings, the resistance of several piezoresistors 
will be measured to assess the typical extent of possible mismatch.  Additionally, 
the piezoresistors’ thermal coefficient will be determined by temperature testing 
 104 
in the laboratory.  With these values, PSPICE circuit simulations will be 
conducted to assess the extent of any impact upon pressure transduction.  
Additionally, thermal simulations will be conducted using COMSOL to evaluate 
any concern from potential Joule heating of the sensor itself upon CSF or 
surrounding tissues. 
Sensor Evaluation 
Sensor testing will entail two primary methods.  First, the specified Amphenol 
matched silicon dies with input cross-coupling and output summing (as produced 
by the manufacturer), shown in Figure 20, will be evaluated uncorrected, to 
examine long-term inherent drift performance (hereinafter referred to as 
Uncorrected Sensor Drift Assessment).  Secondly, a custom sensor will be 
developed using two matched dies independently configured as sensors sharing 
a common absolute gas reference and substrate as described within the Sensor 
Design section and as illustrated in Figure 22 and Figure 23.  The system will be 
laboratory evaluated as next described (referred to as System Calibrated Sensor 
Assessment) and in accordance with the operational methods described in the 
Sensor Design section and in U.S. Patent 9,668,663. 
Uncorrected Sensor Drift Assessment 
The native sensor drift of matched dies in a cross-coupled and output summed 
configuration will be evaluated over an extended period of time using the setup 
shown in Figure 29.  The Amphenol BLVR-L30D-B1NS will be selected for most  
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Figure 29 – Long term drift chamber with external and local power supply 
regulation and thermal stability with data acquisition system under UPS. 
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closely matching the desired pressure range of -500 mm H2O to +500 mm H2O 
and to represent state-of-the-art driftless sensing.  The laboratory setup will 
employ a temperature chamber to maintain a stable operating environment 
throughout the evaluation.  The temperature will be set to 37°C, simulating 
human in-vivo temperature.  Liquid media input pressure will be provided via a 
glass cylinder of water.  Figure 30 is a schematic of the front-end analog 
electronics to be used for amplifying the sensor signal.  The circuit will utilize 
precision linear voltage regulators in addition to an external precision power 
supply.  As provided in the schematic, the Amphenol dual matched-die utilizes 
cross-coupling of the input pressures to opposite sides of the two dies.   
Furthermore, the outputs of the two separate dies are summed prior to 
amplification.  This design and configuration currently represents the most 
advanced commercial device for actively reducing drift.  Periodic measurements 
will be obtained via a data acquisition system (DAQ) as well as periodic manual 
measurements.  The entire system will be sustained via an uninterruptable power 
system (UPS). 
System Calibrated Sensor Assessment 
The setup for evaluating the new custom sensor system’s ability to mitigate offset 
and gain drift will entail emulating in-vivo pressure sources by utilizing a 
reference fluid column (e.g. simulating a peritoneal catheter) and a CSF pressure 
source.  The two dies of the sensor system will be hydraulically connected with 
pressure sources comparable to those in-vivo.  Figure 31 illustrates a benchtop 
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Figure 30 – Front-end circuit for long-term cross-coupled sensor assessment. 
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Figure 31 – Dual biopressure sensor test bench with pressure source, precision power supply, instrumentation 
amplifier, and oscilloscope measurement.
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test system incorporating a burette pressure source which will connect to the 
CSF inlet port of the biosensor.  On the biosensor’s reference inlet will be tubing 
of liquid of a prescribed length terminating into a 2L water reservoir.  The water 
reservoir will simulate a large fluid mass representative of the peritoneum or 
simply the subcutaneous plane.  Gain drift will be induced by modulating the 
sensors’ bridge voltage bias. 
The overall sensor system, including the input pressure sources, will also be 
enclosed within a vacuum chamber, as shown in Figure 32.  This will allow 
modulation of the environmental pressure, simulating either atmospheric 
pressure changes common to the system or a drift of the sensor’s absolute 
reference chamber, necessitating offset correction. 
Figure 33 shows the schematic of the front-end analog circuit to be used for the 
System Calibrated Sensor Assessment.  Compared to the Amphenol 
configuration shown in Figure 30, the two matched dies are decoupled 
electrically and also distinctively share a common top-side absolute gas 
reference.  In this configuration, mathematical signal processing is performed 
post amplification, which allows the sensors to be sampled individually over 
different orientations/positions.  For benchtop testing, precision power supplies in 
close proximity to the system will be used for powering the sensor and test 
circuits. 
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Figure 32 – Isolation chamber with self-contained pressure source for offset 
testing. 
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Figure 33 – Front-end circuit for benchtop testing of system calibrated sensor. 
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The evaluation protocol for the System Calibrated Sensor Assessment will be as 
follows: 
1. Bias the sensor: either to the nominal operating voltage (i.e. ±5.000 VDC) 
or to an offset voltage (e.g. ±4.000 VDC or ±6.000 VDC), to induce a 
known gain drift. 
2. Measure the reference sensor and CSF pressure sensor’s amplified root 
mean squared (RMS) output voltage with the reference pressure line and 
water reservoir in the 0° position (i.e. zero pressure above atmospheric). 
3. Measure the reference sensor’s amplified output voltage with the 
reference pressure line in the -90° downward position (i.e. a pressure of 
Patm – ρgh).  Record the height, h, in addition to the output voltage. 
4. Calculate the gain of the reference sensor using the known reference 
line’s pressure, by virtue of knowing its length/height, liquid density, and 
barometric pressure for the two positions. 
5. With a calibrated barometer reading the station pressure (e.g. located 
either within the vacuum chamber or deduced by a vacuum gauge and 
barometer), measure the biosensor’s environmental pressure.  A vacuum 
pressure may be used to simulate a known pressure sensor offset. 
6. Using the reference sensor’s RMS output signal from its reference 
pressure line in the 0° position, along with the calculated gain, calculate 
the sensor’s offset, b, by equating the signal measurement to the known 
environmental pressure based on the calibrated barometer. 
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7. Using the reference sensor’s gain and offset, calculate the CSF sensor’s 
input pressure. 
8. Compare the measured and corrected CSF inlet pressure to the known 
true CSF input pressure (i.e. liquid level in burette or other source). 
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CHAPTER FOUR  
RESULTS AND DISCUSSION 
In the prior chapter, sensor requirements and research objectives were 
developed based upon research of the literature related to ICP monitoring for 
hydrocephalus and other intracranial hypertension high risk patients.  
Fundamental limitations in current pressure sensing technology for long-term 
monitoring were identified and discussed.  A new novel approach, patented as an 
outcome of this research, was described and developed thereupon.  Methods for 
assessing the latest state-of-the-art driftless sensing technology and the new 
novel approach described herein were developed.  In this chapter, results of the 
methods will be presented along with discussion related to the results and 
challenges thereof.  Chapter Five will assess the results overall with respect to 
potential clinical impact and future steps. 
This chapter is organized into: 1.) Sensor Simulations 2.) Uncorrected Sensor 
Drift Results 3.) System Calibrated Sensor Results, and 4.) Non-Ideal Effects and 
Challenges.  The Sensor Simulations section provides results of PSPICE and 
COMSOL thermal simulations.  The Uncorrected Sensor Drift Results provides 
an assessment of the latest drift-less sensing technology commercially available.  
The System Calibrated Sensor Results section provides results of the new dual 
sensor approach allowing self-calibration of the system to mitigate drift.  This 
section will provide results correlating to the objectives outlined in Table 2, 
including pressure range, resolution, etc.  Finally, the section on Non-Ideal 
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Effects and Challenges will share several of the predominant challenges 
encountered by this research and how they were overcome.   
Sensor Simulations 
Simulations of the sensor’s bridge circuit was performed using Cadence® 
PSPICE.  To properly model the bridge circuit, several unmatched sensor die 
measurements were taken under controlled temperature to measure bridge 
resistance.  Table 4 shows the resistance of three different unmatched bridge 
circuits whereby each bridge piezoresistor was measured at 22.1°C.       
As can be seen from the table, the three different unmatched sensor dies 
produced a large range of resistance compared die to die.  This is due to the 
inherent large parameter drift of diffused resistors in integrated circuit (IC) 
processing which results in poor absolute accuracy [129].  However, the ability to 
ratio match resistors in IC processing is much better, which can be seen by the 
small deviation within each unmatched sensor die’s piezoresistor set.  The 
overall average piezoresistance among all resistors sampled was 2.602 kΩ.  
Amphenol All Sensors modules utilize a second printed circuit board to provide 
additional circuit resistance to produce consistent input and output resistance 
and to trim sensor span.  Furthermore, the additional printed circuit board 
provides twin ground resistors which can be laser trimmed to balance the two 
sides of the bridge and “zero” the output.  These resistors connect to the split 
ground as shown in Figure 13. 
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Table 4 – Sensor bridge piezoresistance at 22.1°C. 
 Unmatched Sensor Bridge 
 A B C 
R1 3,268 Ω 2,472 Ω 2,020 Ω 
R2 3,345 Ω 2,496 Ω 1,998 Ω 
R3 3,351 Ω 2,497 Ω 2,020 Ω 
R4 3,273 Ω 2,466 Ω 2,023 Ω 
AVG. 3,309 Ω 2,483 Ω 2,015 Ω 
% DEV. 1.26% 0.57% 0.38% 
 
To more fully model the characteristics of the sensor bridge, piezoresistance 
measurements were taken over temperature.  Figure 34 plots the acquired data 
for a piezoresistor of 3.096 kΩ at room temperature with a temperature response 
of 8.49Ω/°C, or 2,940 parts per million (ppm) per degree centigrade.  The 
temperature coefficient and measured resistance mismatch of the bridge’s 
piezoresistors were used for simulating potential temperature and offset 
inaccuracies of the pressure sensor.  Figure 35 provides the schematic used for 
PSPICE simulation using the worst deviation in bridge resistance given in Table 
4.  Piezoresistor temperature coefficients of 2,940 ppm were loaded for R1 – R4.  
A simulation of temperatures ranging from 20°C to 40°C were ran.  Figure 36 
shows the resulting piezoresistance variation for R1 ranging from 3.276 kΩ to 
3.473 kΩ.  Figure 37 shows the resulting differential output voltage of the bridge 
over the same temperature range.
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Figure 34 – Piezoresistor temperature response 
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Figure 35 – Sensor bridge PSPICE simulation circuit for piezoresistor mismatch 
and temperature sweep.
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Figure 36 – PSPICE simulation showing piezoresistance for R1 at 20°C, 36°C, 37°C, 38°C, and 40°C. 
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Figure 37 - PSPICE simulation showing bridge output of 329.076 μV for all temperatures 20°C - 40°C. 
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A noticeable offset voltage of 329 μV exists at the output, which is due to the 
piezoresistors’ mismatch.  Temperature variations, however, are almost entirely 
negated by the full-bridge circuit, resulting in only several femtovolts over the 
20°C range.  Provided the nominal resistance of each piezoresistor is close, the 
percent resistance change from nominal is negligible.  Only in the presence of 
temperature gradients does the bridge become unbalanced due to temperature.  
However, temperature imbalances across the face of the die are unlikely due to 
the heat capacity of the contacting liquid media and the small cross-sectional 
area of the sensor.   
A COMSOL simulation was created using the die and ceramic substrate 
geometry to evaluate temperature gradients within the sensor body and any 
impact upon the temperature of CSF.  The simulation was constructed using 
37°C water (99% CSF constituent) stimulating the bottom-side surface of the die.  
Joule heating resulting from the piezoresistors at 5V bias was simulated.  Figure 
38 shows the resulting temperature gradient in which the surface of the die and 
the contacting liquid is uniform at 37.248°C.  At the chip’s ceramic substrate, 
where the port meets the liquid column (or CSF), the temperature was found to 
be 37.018°C.  Therefore, from both the PSPICE and COMSOL simulation, the 
device is both temperature stable and safe in-vivo with near zero heating impact 
to CSF. 
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Figure 38 – Temperature gradient from sensor’s Joule heating upon 37°C CSF.  
Uncorrected Sensor Drift Results 
The latest commercial technology available for drift-less pressure sensing was 
found offered by Amphenol/All Sensors employing dual matched-die cross-
coupled sensors.  The BLVR-L30D-B1NS sensor was selected for evaluation to 
assess the sensor’s drift performance.  Although the sensor module incorporates 
drift correction through the use of both cross-coupled fluid and cross-coupled 
electrical signals, the sensor is otherwise uncorrected relative to this work’s self-
calibrating sensor system.  By sharing input fluid under test with both sensors 
and electrically cross-coupling the outputs, the two sensors module can subtract 
out common-mode induced stress that could otherwise result in measurement 
drift.  Amphenol is the only manufacturer identified by this research to specify 
long-term drift metrics, which for the BLVR in gaseous media is specified at 1.45 
mm H2O at year one.  The sensor drift was evaluated for over two years using 
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the methods previously described in Chapter Three and with the laboratory setup 
shown in Figure 39.  The laboratory setup utilized a Test Equity TEC1 
temperature chamber set to 37°C.  Measurements for room temperature, 
chamber temperature, and output voltage corresponding to pressure were logged 
with a one-minute period using National Instruments’ LabView and the NI USB-
6211 16-bit 250 kS/s data acquisition system.  
The pressure sensor was amplified by a Texas Instruments INA-141 
instrumentation amplifier, which was locally regulated by LM1086 and LM337 
linear regulators.  The sensor’s readout circuit is shown in Figure 30.  Local 
precision power regulation was utilized to minimize any bridge bias voltage effect 
upon drift.  Power supply voltages and input fluid were routinely monitored to 
ensure stability for negligible to zero impact upon drift measurements.  The entire 
system was further powered by an external Hewlett Packard E3620A precision 
power supply and an uninterruptable power system (UPS).  The sensor module 
was configured with a glass cylinder epoxied to its ceramic printed circuit board 
(PCB) for backside die pressure stimulation as shown in Figure 40.  Epoxy 
Technology EPO-TEK 730-110 was selected due to its use in other implantable 
devices.  An initial transfer function was taken prior to long-term testing and is 
shown in Figure 41 revealing an amplified gain of 12.7 mV per mm H2O (or 127 
μV unamplified) and with an offset of 0.7 mm H2O with excellent linearity of 
0.60% full scale span (FSS). 
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Figure 39 – Laboratory setup for uncorrected long-term drift measurement of 
cross-coupled sensor. 
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Figure 40 – Long-term test sensor with pressure cylinder and read-out circuit. 
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Figure 41 – Uncorrected pressure sensor initial transfer function. 
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Approximately 31 mm of water was used for pressurizing the system for long-
term drift testing with a small top layer of mineral oil to mitigate evaporative 
effects within the thermal chamber.  31 mm H2O was chosen as a moderate 
pressure, relative to the overall pressure range of the device, to challenge the 
sensor’s signal-to-noise performance while yet minimizing any small parasitic 
pressure effects upon assessing true drift.  Figure 42 graphs the average daily 
pressure output for 862 days of testing (i.e. 2.4 years).   
By day 27, the pressure sensor’s gauge factor lost 10% of its gain.  A maximum 
occurred at day 841 with a loss of 19.4% gain.  A slight anomaly at day 628 
represents when the thermal chamber was re-setup due to a facility move.  The 
liquid’s top layer of mineral oil was slightly tilted wetting the upper surfaces of the 
cylinder’s interior.  A drop of liquid was added to compensate.  However, the 
mineral oil slowly returned from the inner circumference of the cylinder settling 
upon the top of the water, overall resulting in a 0.9 mm H2O increase in daily 
average pressure.  The sensor’s signal thereafter stabilized.  However, over the 
next five months the sensor’s output increased slightly before encountering 
another significant gain loss, returning to the approximate gain prior to the 
equipment move.    
A linear fit overlaid on Figure 42 approximates a gross gain loss of 18.0% at day 
862.  A transfer function acquired shortly thereafter, at 2.5 years at 31 mm H2O 
pressure stimulation, reveals a more precise 22% gain loss as shown in Figure 
43.  Nevertheless, linearity in the transfer function is nearly perfectly preserved at  
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Figure 42 – Long-term uncorrected pressure sensor drift for 31 mm H2O liquid (BLVR-L30D-B1NS). 
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Figure 43 - Uncorrected pressure sensor initial and 2.5-year transfer function. 
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0.63% FSS (versus 0.60% originally) and with negligible zero shift with less than 
1 mm H2O.  Figure 44 shows the transfer function for two additional matched 
sensor dies, which were used in fabricating a custom device.  The figure shows 
an uncorrected transfer function after six months at room temperature.  The data 
reveals an average decline in gain of 2.75% ±0.97%, with the difference between 
the two dies totaling 0.65%.  Offset drift was negligible.  Extrapolated to 2.5 
years, the estimated gain drift, should it remain constant, would equate to about 
14%.  In this different set of dies, the linearity is again preserved despite the loss 
of gain. Linearity after six months was 0.74% FSS and 0.55% FSS for U1 and 
U2, respectively. 
Three-month baseline and sensitivity studies performed by the University of 
Auckland, New Zealand, for a piezoresistive diaphragm pressure sensor, found 
thermal bonding damage as a prime suspect for die level drift.  Additionally, the 
study identified diaphragm oxidation growth and the deterioration of its photo-
resistive layer as a contributor to changes in gauge factor, or gain [130].  Other 
contributors included inelastic deformation of the diaphragm, effusion of the 
absolute reference cavity, power-cycling thermal effects, as well as drift 
mechanisms arising from DC bias.  The preliminary study concluded that sensor 
drift was found to be bilateral and unpredictable, making a priori design 
compensation challenging.  Esashi et. al. also studied specific drift factors in 
custom fabricated piezoresistive pressure sensors [117].  Their findings identified 
electrical leakage currents and thermal mismatch, particularly between the
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Figure 44 – Six-month drift results for dual pressure sensor build 0517 
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sensor and its support or substrate, to cause drift.  The study stated most of the 
instabilities presented resulted from thermally induced stress upon packaging. 
System Calibrated Sensor Results 
Distinct from the Amphenol cross-coupled pressure inputs and summed electrical 
outputs, this research evaluated decoupled inputs and outputs utilizing a 
common absolute reference chamber with a second hydraulic reference and 
novel calibration approach intended for in-vivo operation.  The approach utilizes 
matched silicon dies, as described in Chapter Three’s Independent Dual-Die 
Dual-Reference BioPressure Sensor section, to evaluate gain and offset of one 
sensor to predict the characteristics of the other matched sensor.  A custom 
pressure sensor module was constructed utilizing Amphenol’s 30 INCH-D-MV 
matched pressure sensor dies.  Figure 45 illustrates an exploded view of the 
custom sensor where on the left-hand side of the illustration is the absolute 
pressure chamber on top, which encapsulates the two top-side dies.  At the top 
right-hand side of the figure is shown independent pressure port chambers for 
bottom-side stimulation of each die.  The substrate in the middle upon which the 
pressure sensor dies are mounted is a 1 mm thick ceramic PCB.  As compared 
to Figure 21, both dies share a top-side absolute pressure chamber source while 
each die’s bottom-side diaphragms are interpedently stimulated. 
The 30 INCH-D-MV dies are monocrystalline bulk micromachined silicon sensors 
of approximately 2 mm x 2 mm area with a mating silicon support structure.  The 
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Figure 45 – Custom dual biopressure sensor exploded illustration. 
dies are mounted bottom-side to their ceramic chip carrier via a low stress deep, 
yet thin, layer of silicone.  Single crystal silicon is the most commonly used 
substrate for micromachined MEMS and has a long history of use in implantable 
devices, including ICP monitors, such as the Codman Microsensor®, as well as 
the NEUROVENT P-tel® and the Sensor Reservoir®.  Kotzar at. al. examined the 
biocompatibility of silicon MEMS, along with commonly associated materials, 
such as titanium, over a range of ISO 10993 tests [131].  Titanium has long been 
used in pacemakers providing hermetic enclosures incorporating glass-to-metal 
seals [132].  Hermetic anodic bonding of bulk micromachined silicon pressure 
sensors to glass has additionally been reported and demonstrated [91].  Corning 
7740 (Pyrex®), Corning 7070, Corning 1729, Corning 9626, Schott 8330 
(Tempax®) and SD-2 (HOYA) are all among the most prominent glass materials 
given their close thermal coefficients to silicon [133].  Glass to metal seals’ 
biocompatibility has been examined to be robust [134].  Kotzar examined both 
aqueous and non-aqueous physiochemical tests, cytotoxicity, extractables, and 
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histopathology for explanted silicon and associated MEMS materials as well as 
titanium materials.  Kotzar further examined the test materials both post-
sterilization and explantation for in-vivo damage or alteration under scanning 
electron microscopy (SEM).  All tests results indicated safe biocompatibility, 
including compatibility with prevailing sterilization techniques, such as gamma 
and autoclaving, without damage to the materials.  Silicone elastomer materials 
have additionally proven a long history of biocompatibility, particularly in the 
brain, where its first recorded CNS use dates back to the 1950’s by Robert 
Pudenz and Richard Ames for use as long-term shunt catheters [135].  All 
considered, the selection of the 30 INCH-D-MV die and associated materials, or 
the additional choice of mating materials which may be used in the fabrication of 
the finished implant, represent biocompatible materials with hermetic capabilities, 
meeting the requirements of R1.0 and following objectives. 
The 30 INCH-D-MV dies provide ±762 mm H2O of linear pressure range with a 
proof pressure (i.e. maximum applied pressure without permanently changing 
performance) of ±5,080 mm H2O (i.e. ±one-half atmosphere).   Burst pressure of 
the 30 INCH-D-MV die occurs at ±2.0 atmospheres.  The 30 INCH-D-MV sensor 
die outputs were mounted upon a ceramic substrate and independently bonded 
and pinned out to a secondary printed circuit board, as shown in Figure 46.  
Custom pressure sensor chambers were fabricated, as shown in Figure 45, from 
Polymethyl Methacrylate (PMMA) for laboratory evaluation purposes.  The top-  
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Figure 46 – Custom dual matched die biopressure sensor prototype showing 
absolute reference chamber and top-side dies therein. 
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side chamber, as shown in Figure 46, provides a rigid absolute pressure 
chamber, common to both dies, while another set of separate chambers provide 
independent pressure ports for each bottom-side die, consistent with Figure 21.  
Figure 47 shows one of the finished custom pressure sensors configured for 
laboratory evaluation, identified as Build 0517, with an absolute pressure 
chamber of approximately 28.92” Hg (9,987 mm H2O).   
For operation, both of the sensors were biased at +5 VDC producing a nominal 
zero pressure output of +2.5V.  The output signals were amplified using an 
Analog Devices AD8222 instrumentation amplifier for reasons described in the 
Electronics Readout Overview section.  The AD8222 was biased at ±10 VDC 
whereby the nominal output voltage was zero for zero input pressure.  Backside 
die pressure produced a negative going signal in each sensor.  However, the U1 
output was measured positively with respect to the common mode point and U2 
was measured negatively.  Figure 48 shows a schematic of the front-end readout 
circuitry used in laboratory measurements.  Figure 49 shows the recorded 
transfer function for the custom dual sensor build resulting from independent 
backside die stimulation.  Gain of U1, determined from the best-fit straight line, 
was 10.92 mV/mm H2O while U2 was 10.64 mV/mm H2O.  Linearity was found to 
be 1.03% and 2.36% FSS, respectively.  Zero offset for U1 was 1.65 mm H2O 
and 3.41 mm H2O for U2.  
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Figure 47 - Custom dual matched die biopressure sensor prototype showing both 
independent chambers and top-side reference chamber. 
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Figure 48 – Custom dual matched-die sensor readout circuit. 
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Figure 49 – Custom dual biopressure sensor transfer function (Build 0517). 
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The sensor die’s pressure range of ±500 mm H2O was confirmed in the custom 
module, as shown in Table 5, with an absolute error of less than 1%.  Figure 50 
shows the acquired signal for +502 mm H2O revealing a standard deviation from 
mean level for n=100 samples of 0.69 mm H2O.  Likewise, Figure 51 shows the 
acquired signal for -499 mm H2O with a similar standard deviation of only 0.72 
mm H2O.  Overall, the measured pressure range satisfies objective O3.1. 
Table 6 tabulates resolution measurements for both dies given 3σ noise levels.  
Noise levels were observed to increase with pressure until a plateau occurred 
around 150 mm H2O.  Overall, the 3σ resolution was 3.0 mm H2O for U1 and 3.4 
mm H2O for U2, meeting the objective set forth in O3.2 of less than 10 mm H2O.  
The limit of detection (LOD) was found from the noise at 0 mm H2O to be 2.3 mm 
H2O for U1 and 3.3 mm H2O for U2.  For levels above 200 mm H2O, the data, 
including that from full range testing and Table 6, reveals resolutions of 
approximately one percent or better. 
For repeated accuracy measurements, including the measurement of both 
trueness and precision, 150 mm H2O was selected for assessment since it 
produced the worst noise figures over the sensor’s range (see Table 6).  Table 7 
provides accuracy statistics for n=100 samples while Figure 52 and Figure 53 
show samples of measured signals.  A maximum mean error of -3.73 mm H2O 
between the two sensors was measured with U1.  However, the error measured 
was within the objectives of O3.3, or ±5 mmH2O. 
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Table 5 – Sensor Pressure Range Verification 
 
Vrms Vrms Offset 
Gain 
mV/ 
mm 
H2O 
Measured 
Pressure 
mm H2O 
Actual 
Pressure 
mm H2O 
Error 
mm H2O 
Error 
% 
+500 mm H2O 5.37 -0.0221 10.64 506.78 502 4.78 0.95% 
-500 mm H2O -5.38 -0.0221 10.64 -503.56 -499 -4.56 0.91% 
 
 142 
 
Figure 50 - +502 mm H2O signal 
 
 
Figure 51 - -499 mm H2O signal 
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Table 6 – Sensor resolution summary 
 
Pressure 
mm H2O 
Noise, σ 
mV 
3σ 
mV 
3σ 
mm H2O 
Average 
Resolution 
mm H2O 
U1 
0 8.1 24.3 2.3 
3.0 100 7.7 23.2 2.2 150 13.5 40.5 3.9 
300 13.2 39.7 3.8 
U2 
0 11.5 34.5 3.3 
3.4 100 8.1 24.3 2.3 150 16.3 48.9 4.7 
300 12.0 36.1 3.5 
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Table 7 – Accuracy measurements for sensors U1 and U2, n=100 
 
Vrms Vrms Offset 
Gain 
mV/ 
mm H2O 
Measured 
Pressure 
mm H2O 
Actual 
Pressure 
mm H2O 
Error 
mm H2O 
Error 
% 
σ 
Vrms 
3σ 
mm 
H2O 
U1 150 mm H2O 1.59 -0.008 0.010925 146.27 150 -3.73 -2.48% 0.00105 0.29 
U2 150 mm H2O -1.57 -0.005 -0.01064 147.10 150 -2.90 -1.93% 0.00365 -1.03 
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Figure 52 – Accuracy measurement for sensor U1, 150 mm H2O, n=100 samples 
 
 
Figure 53 - Accuracy measurement for sensor U2, 150 mm H2O, n=100 samples 
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Manual power cycle tests were performed for 150 mm H2O to measure 
reproducibility, or precision.  Figure 54 shows the resulting histogram of 100 
samples revealing a mean pressure of 151.29 mm H2O.  The standard deviation 
was 0.387 mm H2O with 3σ equaling 1.16 mm H2O.  The range was 1.8 mm H2O 
and the mean absolute error was 1.29 mm H2O.  The reproducibility assessment 
meets the precision objective of ±5 mm H2O of O3.4.  Given the maximum error 
for the worst noise figures measured over the range, the combined trueness and 
3σ reproducibility results in an accuracy of 4.89 mm H2O.  For pressures beyond 
200 mm H2O, including 500 mm H2O, a maximum error of 3.8 mm H2O was 
found with U1 at 300 mm H2O, or 1.26%, well within the objective of O3.5.  
To explore the dual matched dies’ capability to mitigate gain and offset drift with 
the system calibration described in Chapter Three, the sensors’ bridge bias and 
common mode pressure was modulated.  Bridge bias was adjusted from 80% to 
100% (5 VDC) to 120% to induce sensor gain shifts of ±20%. 
Figure 55 shows the resulting pressure-voltage transfer functions for the new 
custom dual-die pressure sensor module.  Both of the sensors’ gain response 
was measured with a maximum gain difference between the two matched 
sensors of +0.65% and -0.3% over the full range of 80% to 120% gain shift. 
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Figure 54 – Precision measurement histogram for 150 mm H2O and n = 100 
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Figure 55 - Dual sensor die comparison for 80%, 100%, and 120% gain.
 149 
A hydraulic and pneumatic test system was setup according to that described in 
Chapter Three.  The laboratory setup is shown in Figure 56, Figure 57, and 
Figure 58.  The test system was designed to assess the custom dual matched 
die system’s performance under induced gain and offset shift.  Figure 56 shows 
the test and measurement system, including a graduated burette simulating a 
ventricular pressure source.  Figure 57 shows the reference fluid column and 2L 
water reservoir simulating the peritoneum.  Figure 58 is the test setup’s vacuum 
pressure chamber used for inducing an offset pressure relative to the sensor’s 
integrated absolute pressure chamber.  An enclosed input pressure source 
consisting of a drying tube simulated ventricular pressure. 
 
Figure 56 – Custom dual biopressure sensor system test bench. 
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Figure 57 – Reference reservoir for liquid fluid column. 
   
Figure 58 - Isolation pressure chamber with self-contained pressure source. 
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The new dual matched-die pressure sensor module was subjected to gain drifts 
of +20% and -20% to evaluate the system’s ability to accurately negate the error.  
Barometric pressure (i.e. station pressure) at the time of testing was 29.138” Hg 
(10,062 mm H2O), representing an offset of 75 mm H2O (10,062 barometric less 
the integrated absolute chamber’s pressure of 9,987 mm H2O).  The sensor 
module’s reference fluid column was approximately 445 mm in length and the 
height of the reservoir was measured upon each positioning from 0° to -90°.  
Table 8 outlines the results of the custom sensor’s self-calibration utilizing its 
reference fluid column. 
For measurement series one, for example, an input stimulus of 100 mm H2O 
(above barometric) was used to simulate ventricular pressure.  A gain deficit 
of -20% was induced for the test.  A 440 mm reference fluid column was 
connected to one of the two sensor dies (i.e. the reference die).  For a patient 
deployment, the reference column length would be recorded upon implant.  The 
system was then operated in calibration mode as if it were in-vivo.  Signal 
measurements were taken by placing the reference column in both the 0° 
and -90° positions, as recorded in Table 8.  The gain was then derived from 
single-ended measurements of the reference die, as follows: 
𝐴௩ି௥௘௙ ൌ െ0.449 െ ሺെ4.110ሻ 𝑉െ440 𝑚𝑚 𝐻ଶ𝑂 ൌ 0.008320455
𝑉
𝑚𝑚 𝐻ଶ𝑂 
Next, the offset was calculated, based on the gain, using slope-intercept form.  
Barometric pressure was measured using the iPhone® Bosch BMP-280,  
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Table 8 – System calibrated dual matched-die sensor results at gain ±20% 
 Measurement Series 
Known Test 
Parameters 1 2 3 4 5 6 
Sensor Bridge Bias (V): 4.00 5.00 6.00 4.00 5.00 6.00 
Sensor Bridge Bias 
(%): 80% 100% 120% 80% 100% 120% 
CSF Test Pressure 
(mm H2O): 100 100 100 150 150 150 
Barometric Pressure 
(mm H2O): 
  
10,033  
  
10,039  
  
10,038  
  
10,038  
  
10,038  
  
10,038  
Ref. Column Pressure 
(mm H2O): -440 -444 -443 -444 -445 -445 
       
0⁰ Position Signals       
CSF (Vrms): 0.385 0.621 0.481 0.769 0.968 1.390 
Ref (Vrms): -0.449 -0.428 -0.799 -0.478 -0.611 -0.517 
       
-90⁰ Position Signals       
CSF (Vrms): 0.457 0.597 0.535 0.848 1.090 1.310 
Ref (Vrms): -4.110 -5.180 -6.390 -4.210 -5.260 -6.280 
       Derived Gain and 
Offset       Measured Gain (V/mm 
H2O): -0.0083 -0.0107 -0.0126 -0.0084 -0.0104 -0.0130 
Measured Gain (from 
nominal): 78% -- 118% 80% -- 124% 
Offset (V): 83.03 107.02 125.89 83.90 104.26 129.48 
       CSF Pressure (mm 
H2O): 100.2 98.0 101.4 148.4 151.1 147.3 
Error: 0.23% -1.99% 1.42% -1.10% 0.76% -1.83% 
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providing a specified 0.10 mm H2O resolution and typical accuracy of 1.22 mm 
H2O [136].  In a patient setting, the barometric pressure would be read ex-vivo 
and equated to the reference die’s pressure reading in the supine, or 0° position, 
whereby the column pressure would be approximately zero. 
𝑏 ൌ െ0.449 𝑉 െ 10,033 𝑚𝑚 𝐻ଶ𝑂 ∗ ሺെ0.0083205 𝑉𝑚𝑚 𝐻ଶ𝑂ሻ ൌ 83.03 𝑉  
Finally, with the gain and offset derived from using the sensor system’s reference 
fluid column and externally measured barometric pressure, the ventricular 
pressure may be determined.  The gain and offset values for the reference 
sensor can be applied to the ventricular pressure sensor, by virtue of matched 
dies, and intracranial pressure calculated as follows: 
𝑃஼ௌி ൌ 𝑎𝑏𝑠 ൮ 0.385 𝑉 െ 83.03െ0.008320455 𝑉𝑚𝑚 𝐻ଶ𝑂
െ 10,033 𝑚𝑚 𝐻ଶ𝑂൲  ൌ 100.2 𝑚𝑚 𝐻ଶ𝑂 
The absolute value is taken due to the negative going signals arising from bottom 
side die stimulation.  As can be seen from this measurement series, the actual 
versus derived CSF pressure resulted in an error of only 0.23% for a -20% gain 
drift and a 75 mm H2O offset.  Measurements were taken for ±20% induced gain 
drifts with the same 75 mm H2O offset for both 100 and 150 mm H2O simulated 
ventricular pressure.  All measurements were within 2% of actual input pressure. 
Table 9 provides the results of further inducing an offset using the  
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Table 9 - System calibrated dual matched-die sensor results for induced offset 
Known Test Parameters Measure- ment #1  
Measure- 
ment #2 
Sensor Bridge Bias (V): 5.00  5.00 
Sensor Bridge Bias (%): 100%  100% CSF Test Pressure (mm 
H2O): 150  150 Barometric Pressure (mm 
H2O): 10061  9810 Ref. Column Pressure (mm 
H2O): -254  -254 
    0⁰ Position Signals    
CSF (Vrms): 0.805  -1.45 
Ref (Vrms): -0.791  -3.07 
    -90⁰ Position Signals    
CSF (Vrms): 0.791  -- 
Ref (Vrms): -3.491  -- 
Derived Gain and Offset 
Measured Gain (V/mm 
H2O): -0.01063  -0.01063 
Offset (V): 106.16  101.21 
    
CSF Pressure (mm H2O): 150.14  152.40 
Error: 0.09%  1.60%  
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isolation/vacuum pressure chamber shown in Figure 58.  A simulated ventricular 
pressure of 150 mm H2O was used in both measurements.  Measurement 1 was 
taken outside the chamber to facilitate gain determination using the two different 
reference column positions.  The calculated gain and offset at normal barometric 
pressure resulted in a CSF calculation of 150.14 mm H2O, almost precisely the 
known true input.  Measurement 2 was taken thereafter entirely within the 
pressure chamber at a reduced environmental pressure of -9.9” H2O (i.e. -251 
mm H2O) as shown in Figure 59.  This resulted in an absolute environmental 
pressure of 9,810 mm H2O.  For Measurement 2, the system’s reference column 
line was flat against the bottom of the chamber, representing the 0° position and 
then the new offset was calculated.  90° signal measurements within the 
chamber were not necessary, or feasible, as the gain was determined outside the 
chamber.  As can be seen from the table, the 150 mm H2O pressure voltage 
shifted from +0.805 V to -1.45 V due to the environmental change.  The derived 
offset shifted from 106.16 to 101.21.  Combined, the CSF pressure derived for 
Measurement 2 within the chamber was 152.40 mm H2O, representing only a 
1.60% error.  The test demonstrates the ability of the sensor system to correct 
large baseline shifts.  Without the offset correction, the resulting error would have 
been over 100%. 
Figure 60, Figure 61, and Figure 62 graph the test results of the system 
calibrated custom biopressure sensor.  For 150 mm H2O and either a gain of 
±20% or offset of approximately 250 mm H2O, the maximum error from true 
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Figure 59 – Vacuum pressure chamber measurement 
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Figure 60 – System calibrated dual sensor performance for 100 mm H2O and 
induced gain shift. 
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Figure 61 - System calibrated dual sensor performance for 150 mm H2O and 
induced gain shift. 
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Figure 62 - System calibrated dual sensor performance for 150 mm H2O and 
induced offset shift. 
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ventricular pressure was 2.75 mm H2O, or 1.83%.  For 100 mm H2O, the 
maximum measured error was 1.99%.  The system meets the objectives of O4.3 
for gain and offset correction.  Furthermore, for the extent of gain and offset 
induced and the corresponding calibration results, the sensor is anticipated to 
correct drift to within ±50 mm H2O over its expected service life per O5.1. 
Although the research focus of this work is upon the system calibrated 
biopressure sensor and interface, as outlined in Figure 26, requirements were 
nevertheless considered in R4.0 that the sensor support non-invasive readout.  
The power consumption, signal levels, and geometry all come under 
consideration to facilitate such an implantable non-invasive readout system.  
Figure 26 illustrates one potential system design employing the Texas 
Instruments® TE CC2541 for providing Bluetooth Low Energy communications to 
and from the transponder.  The CC2541 additionally integrates a 12-bit analog-
to-digital converter (ADC) supporting an input range from 0 to 3.6 V.  The 
laboratory front-end circuit given in Figure 48 can be modified to support the 
CC2541’s ADC by reducing the gain of the instrumentation amplifier (IA).  
Although the laboratory’s front-end circuit could be passively or actively 
attenuated to optimize the circuit’s signal to noise ratio, doing so would consume 
additional power.  Provided the sensor signal is amplified close to the die, 
reducing the IA may be the best compromise to preserve power consumption.  
Figure 63 shows the schematic of the reconfigured front-end circuit biased by a 
common positive rail of +5V with a reference of 1.54V to shift the output of the IA 
to support both positive and negative pressure signals.  The sensor’s +5V bridge  
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Figure 63 – 5V front-end circuit design with Vo of 0-3.08 V supporting TI CC2541 
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bias is the same as that used by the sensor’s laboratory testing.  The IA output 
range is designed in the circuit to support -1,000 mm H2O to +1,000 mm H2O 
over a 0 to 3.08V range with 1.54V representing the zero-pressure signal level.  
Therefore, the sensor’s front-end electronics can be configured for compatibility 
with the TI CC2541 ADC per O4.1.Operating power consumption of the primary 
components outlined in Figure 25 was calculated and is shown in Table 10.  
Altogether, the custom dual matched-die transponder providing Bluetooth LE 
communications and wireless inductive powering is calculated to consume 
roughly 146 milliwatts.  The amount of power that can be safely transmitted 
transcutaneously into humans has been studied and outlined by the Institute of 
Electrical and Electronic Engineers (IEEE) in standard C95.1 [137].  Maximum 
permissible exposure (MPE) for the general public in the frequency range of 
Bluetooth 4.0 or 5.0 (i.e. 2.4 GHz) is limited to 10 watts per square meter 
averaged over 30 minutes.   
Sampling of the biopressure sensor transponder in two patient positions is 
anticipated to consume no more than 30 seconds of powering and 
communications in total (assuming one ICP sample per 30-minute period).  With 
respect to the power transmission exposure area, the TI BQ500210EVM, as an 
example Qi transmitter, utilizes a 44 mm diameter coil, resulting in an area of 
6,079 mm2.  The total permissible power transmission for this area, according to 
the standard, is 60.8 mW averaged over thirty minutes.  Equivalently averaging 
this limit over 30-seconds of a 30-minute period results in 3.648 W, which is 25x  
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Table 10 – Power consumption of transponder’s main components. 
 Power  (mW) Notes 
Sensor Die 1 8.3   At 5V bias. 
Sensor Die 2 8.3   At 5V bias. 
U1 IA 5.5   At 5V bias. 
U2 IA 5.5   At 5V bias. 
TI CC2541 60.1   In active transmit mode. 
STWLC04 58.5   60% efficiency 
Total: 146.2   milli-watts 
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the power estimation tabulated in Table 10 for the transponder.  Therefore, the 
transponder’s power requirements for transcutaneous transfer meets the safety 
limits of IEEE C95.1 as specified by O4.2. 
pressure upon a resting hydrophobic surface.  At any liquid-gas interface, a 
molecule residing at a free surface of the liquid will encounter a weaker binding 
energy than that within the bulk, thereby resulting in a net positive surface 
energy.  For water, this surface energy is 72 milli-Joules per square meter (or 
milli-Newtons per meter) at 25°C.  To minimize the liquid’s surface energy state, 
higher energy surface molecules are minimized via cohesive intermolecular  
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Table 11 outlines the main component volumes for the transponder comprising a 
PCB substrate, sensors, readout electronics, power reception and regulation 
electronics, Bluetooth LE transceiver, and antenna component.  The volume 
consumed is just under 3,000 mm3.  The maximum volume of a typical CSF 
reservoir dome indicated by O2.1 is 3,464 mm3.  Therefore, the biopressure 
sensor’s transponder components meets the objectives of O2.1 with volume 
remaining. 
Non-Ideal Effects and Challenges 
During the course of this research numerous challenges arose with most being 
related to the measurement of very low pressures and challenges with small 
scale fluid transfer.  Pressures distinguished by this work were on the order of 1 
mm H2O.  Due to surface tension, a mere drop of water typically poses twice this 
pressure upon a resting hydrophobic surface.  At any liquid-gas interface, a 
molecule residing at a free surface of the liquid will encounter a weaker binding 
energy than that within the bulk, thereby resulting in a net positive surface 
energy.  For water, this surface energy is 72 milli-Joules per square meter (or 
milli-Newtons per meter) at 25°C.  To minimize the liquid’s surface energy state, 
higher energy surface molecules are minimized via cohesive intermolecular  
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Table 11 – Transponder primary component volumes 
Component X mm 
Y 
mm 
Z 
mm 
Volume 
mm3 
Substrate 15.00 29.00 1.57 683.0 
Sensor Die 1 2.10 2.10 0.65 2.9 
Sensor Die 2 2.10 2.10 0.65 2.9 
U1 IA 4.10 4.10 0.80 13.4 
U2 IA 4.10 4.10 0.80 13.4 
TI CC2541 6.15 6.15 1.00 37.8 
STWLC04 3.09 4.70 0.55 8.0 
Antenna (DIA) 33.00 33.00 0.64 2198.5 
      Total: 2,960 mm3 
 
  
 167 
forces, resulting in minimal surface area.  These internal surface forces are 
referred to as surface tension.  Surface tension can easily result in several 
millimeters of water pressure in a closed system.  The capillary effect, resulting 
from both cohesive intermolecular forces and adhesive forces to a surrounding 
vessel, is known to lift the sap in trees and plants several meters.  While the 
benefits of these properties are abundant and critical, their effect can be 
detrimental in a low pressure measurement system. 
As an example, Figure 64 shows the effects of initial outgassing from polyvinyl 
chloride (PVC) tubing used to hydraulically couple a liquid pressure source to 
one of the pressure sensors studied.  While these bubbles certainly have a 
limited impact upon occupying volume within the system and increasing the 
liquid’s pressure, they have not yet maximized their effect.  With time, on the 
order of 24 hours, the microbubbles aggregate into air pockets making full 
contact with the interior circumference of the tubing as shown in Figure 65.  At 
this point, surface tension and capillary effects take their toll upon accurately 
measuring the system’s desired liquid pressure reservoir.  Their effect reduces 
the reservoir pressure sensed by the sensor.  Additionally, surface tension 
effects at edge interfaces were examined to withstand relatively large pressures 
before translating head pressure to the system.   
The most challenging of air pockets was within the sensor die itself and its 
mating ceramic through-hole.  Although the volume is estimated at only little 
more than 1 mm3, as tabulated by Table 12, the resulting moisture transfer  
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Figure 64 – Initial outgassing of polyvinyl chloride (PVC) tubing. 
Figure 65 – Bubble formation and air voids from advanced outgassing of tubing. 
 169 
Table 12 – Sensor and supporting substrate cavity volume. 
Cavity L (mm) W (mm) H (mm) Radius (mm) 
Volume 
(mm3) 
Ceramic Through-Hole  -- -- 1.000 0.362 0.412 
Chip Support  -- -- 0.257 0.362 0.106 
Si sensor  1.487 1.487 0.335 -- 0.741 
    Total: 1.258 mm3 
 
caused very non-linear and unstable pressures.  Figure 66 charts the air-liquid 
transfer that began to occur within the first several days of pressurizing the BLVR 
sensor with liquid.  The data shown was acquired using a National Instruments 
DAQ system utilizing a sampling period of one-minute.  Corresponding 
observations of bubble formation are superimposed on the graph.   
As can be seen from the graph, a sharp increase in pressure of approximately 13 
mm H2O occurs upon the initial condensation of liquid occupying the unwetted 
silicon cavity.  A slight convex expansion of gas can next be observed just 
covering the sensor port.  The following exponential response results from the 
slow fluid transfer occurring between the sensor’s bottom-side air cavity and the 
liquid pressure chamber.   
Air-liquid transfer was observed over five distinct phases, and the process is 
hypothesized as follows: 
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Figure 66 – Sensor cavity air-liquid transfer and bubble formation. 
  
 171 
1. The initial air-liquid boundary interface, whereby surface tension and the 
air cavity’s counterpressure counteract the liquid’s hydrostatic pressure, 
maintains near-term equilibrium. 
2. Water vapor transfer resulting from unequally bonded surface molecules 
on the liquid’s surface concentrates within the chip’s air cavity and 
condenses, resulting in initial mass transfer and air displacement.  In this 
phase, pressure sharply increases, and a surface bubble begins to form 
on top of the ceramic substrate’s port hole.  Vapor transfer increasingly 
alters at this point due to the increased pressure within the air cavity. 
3. Continued liquid mass transfer occurs resulting in a growing gas bubble 
with increased interior pressure yet with surface tension preventing 
complete displacement. 
4. Additional accumulating water vapor condenses inside the pressure 
sensor’s cavity further displacing air and increasing the size of the bubble.  
The bubble then extends beyond the circumference of the ceramic port 
hole and forms an underside curvature that results in a growing buoyant 
force due to the liquid’s pressure gradient from the bottom of the spherical 
shape to the top.  Although pressure within the sessile bubble increases, 
as evident by the diameter of the bubble versus the hydrostatic exterior 
pressure, the bubble’s upward buoyancy force reduces pressure within the 
sensor’s cavity.   
5. Once buoyant forces exceed the partial bubble’s surface tension forces 
surrounding the circumference of the pressure port, then the air pocket 
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ascends in the form of a complete sphere.  Spherical shape is maintained 
upon evacuation whereby liquid water minimizes its surface energy 
counterbalanced by the positive pressure within the air bubble.  At this 
point of equilibrium, distributed contraction forces equal the bubble’s 
interior pressure by the Young-Laplace law [138]:  
∆𝑝 ൌ 2𝛼𝑟  
where Δp is the difference in pressure from within the sphere versus the 
exterior for a given bubble radius, r, and where α is the surface energy (or 
tension), which for water is approximately 70 mJ/m2 (or 70 milli-
Newtons/m) at 37°C.  Relative positive pressure exists toward the center 
of curvature.  
Steps 1 through 5 repeats until the entire cavity is at final equilibrium with stable 
pressure.   
To gain further insight into this process a COMSOL Multiphysics simulation was 
undertaken.  A 2-D axisymmetric two-phase flow, phase-field, study with heat 
transfer and moisture transport was setup for the sensor geometry under 4 mm 
of water pressure.  The model utilized the Cahn-Hilliard equation with a chemical 
potential to represent the diffuse interface between the immiscible liquid and air 
domains.  The Navier-Stokes equations were used for fluid transport and 
conservation of mass.  Wetted walls were used for simulating surface tension or 
capillary effects encompassing a glass pressure cylinder atop the sensor’s 
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ceramic substrate and the silicon support structure and sensor itself.  The heat 
transfer from the sensor to the liquid was modeled by convection in moist air, as 
shown in Figure 38.  Initially, the liquid pressure chamber contained 4 mm of 
water with a hydrostatic pressure of ρgz at the sensor’s inlet port.  The initial 
conditions for the sensor’s port cavity was set to 40% humidity.  Environmental 
conditions were set to 1 atmosphere at 37°C.  Figure 67 reveals the pressure 
gradient after 90 minutes showing the pressure presented to the surface of the 
sensor, without any bubble formation, is indeed 4 mm H2O.   
The concentration of water vapor at 90 minutes is shown in Figure 68 with 
approximately 2.43 moles of water vapor, or 99.76% relative humidity.  The 
difference in dew point and the cavity’s ambient temperature under this pressure 
is only -0.05°C before condensation occurs.  Figure 69 shows the water volume 
fraction of the assembly revealing only partial liquid penetration into the cavity 
under surface tension resistance.  Figure 70 shows the corresponding fluid 
velocity of very small volumes at 100 to 250 microns per second.  Convergence 
beyond 90 minutes for the multiphysics model was not achievable.   
 174 
 
Figure 67 – COMSOL axisymmetric pressure gradient. 
 
 
Figure 68 - COMSOL axisymmetric water vapor concentration. 
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Figure 69 - COMSOL axisymmetric water volume fraction. 
 
 
 
Figure 70 - COMSOL axisymmetric fluid velocity. 
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A re-setup of the model to include various forms of partial spherical microbubbles 
in contact with the ceramic substrate’s port hole was unsuccessful at modeling 
the actual observed behavior.  The intent of the bubble simulation was to 
evaluate fluctuating pressures produced within the sensor’s cavity.  However, 
within milli-seconds, the simulation collapsed the bubble and generally returned 
to the state of the prior model.  It was therefore not possible to model the full 
behavior, including partial bubble formation adhered to the substrate, over 
several days.  Nevertheless, the COMSOL simulation provided insight into the 
cavity’s pressure in the absence of a bubble and to convey the extent of water 
vapor concentration within a short period of time. 
Further challenges with air pockets were encountered beyond outgassing and 
air-liquid fluid transfer.  Nucleation of microbubbles from entrained air was 
common with fresh water.  The bleeding of air from small crevices and other 
cavities also had to be overcome.  As can be seen in the lower right-hand 
quadrant of Figure 64, a venting port, later sealed with a viscous hard glue, was 
used to initially bleed the system.  Unfortunately, each of these air voids would 
result in compression and potentially alter the baseline measurement of the fluid 
column’s pressure as pressure was increased (such as in transfer function 
testing).  By the Ideal Gas Law, pressure and volume have an inverse 
relationship, thereby as more pressure was added to a burette source, any 
downstream air pockets would compress and shift the total column of liquid, 
resulting in non-linearity in the measurement.  For measuring transfer functions, 
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resolution, and other measurements, shifts of only a few millimeters could have 
significant impact.  Therefore, it became paramount to eliminate gas sources 
such as entrained air in test liquids.  Materials with significant outgassing was 
either eliminated (e.g. PVC), minimized via surface area, or mitigated though 
vent ports until outgassing diminished (e.g. epoxied materials). 
Additional challenges early in the research ensued with top-side liquid media 
contact.  Figure 71 shows a microphotograph of metal migration eventually 
resulting from distilled water testing, which quickly turned conductive.  The allure 
of top-side liquid sensing was the alleviation of challenges with the bottom-side 
sensor cavity as described above.  Some manufacturers, such as TE 
Connectivity, conduct top-side die biosensing with the use of a dielectric silicone 
gel for fluid isolation.  However, the TE Connectivity device earlier described is 
limited to 72 hours use, likely in part due to the permeability of the gel. 
Further PV=nRT effects were encountered by the custom dual biopressure 
sensor’s absolute pressure chamber.  The chamber is shared by both top-side 
dies, as shown in Figure 21 and Figure 45, and is temperature sensitive.  The 
volume of the top-side chamber is approximately 180 mm3.  For a chamber 
sealed at standard atmospheric pressure and 21°C, the number of moles of air 
within the chamber equates to 7.46 micromoles.  Under normal circadian 
fluctuations in brain temperature of 0.2°C, this results in only 7 mm H2O change 
over the period.  Given the biopressure sensor’s deployment, which is intended  
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Figure 71 – Top-side die metal migration from liquid media contact. 
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to encounter only very short timeframes between two position calibration 
measurements, temperature fluctuation is of low concern.  However, during 
thermal chamber testing in the laboratory, large temperature shifts occurred 
during the opening and closing of the chamber’s door, which was captured in 
data acquisition, as shown in Figure 72.   
Figure 72 shows the converted pressure read by each pressure sensor, U1 and 
U2.  The setup for this particular snapshot of data was that each die had 
individual bottom-side pressure stimuli of equal pressure.  However, due to fluid 
transfer earlier described, this particular acquisition period revealed an offset 
between the two dies.  Furthermore, a large offset was induced by the change in 
temperature of the absolute pressure chamber from room temperature 
construction to chamber testing, resulting in absolute pressure readings much 
higher than otherwise expected.  In essence, this snapshot of data altogether 
captures several of the non-ideal effects encountered.   
Of particular relevance was the change in pressure for both dies resulting from 
the change in temperature of the chamber door opening.  For U2, for example, 
the pressure reading just prior to opening the chamber door was 309 mm H2O 
with a temperature probe in the chamber reading 36.25°C (the chamber’s 
standard sensor read 37.0°C).  One minute after opening the door, the 
temperature probe read 26.79°C and the pressure reading increased to 664 mm 
H2O (+355 mm change).  While it would intuitively seem that the pressure 
reading should drop with a reduction in temperature, it should be noted that the  
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Figure 72 – Custom dual biopressure sensor absolute reference temperature 
response. 
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pressure chamber stimulates the top-side of both dies counteracting bottom-side 
liquid stimulation.  Therefore, a drop in top-side pressure from a reduction in the 
absolute pressure chamber’s pressure would equivalently result in an increased 
pressure reading bottom-side.  The ideal gas law predicts a shift of 334 mm H2O 
for the chamber’s 9.5°C cooling.  However, a shift of only 0.6°C further matches 
the measured 355 mm H2O change, which is conceivable given the temperature 
probe was not placed directly onto the sensor’s reference chamber, but further 
interior to the thermal chamber.   
Additional consideration to the absolute pressure reference is necessary with 
respect to barometric pressure shifts.  Similar to the effect of a large temperature 
swing upon the reference’s pressure is the opposite effect of a large common-
mode pressure swing to bottom-side sources such as that under atmospheric 
pressure shifts.  As described in the Sensor System Design section, extreme 
barometric pressures can span from 8,872 mm H2O on the low end up to 11,472 
mm H2O on the high end, a 2,600 mm H2O range.  Further to this point, on an 
airline flight, environmental pressures were recorded that spanned from 10,298 
to 8,375 mm H2O between near sea-level take-off to a cruising altitude of 9,449 
meters (31,000 feet), a difference of 1,923 mm H2O.  However, the former 
weather pressure metrics were under extreme conditions and from world records 
such as a cyclone’s interior pressure.  The latter pressure range, taken during 
flight, was under conditions untypical of measuring ICP.  Nevertheless, the 
sensor dies utilized within this research have a burst pressure of over 20,000 mm 
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H2O and a proof pressure of 5,080 mm H2O.  During the course of this work, no 
non-linearity effects upon the sensors transfer function was observed, even 
under induced offset testing.  As a more practical range, over the almost three-
year period sensor testing was conducted, local barometric pressure conditions 
varied a maximum of 535 mm H2O.  In any event, should a further increase in 
tolerance to very large environmental pressure swings become necessary, 
matched pressure sensor dies could be fabricated at the potential expense of 
resolution. 
Altogether, the non-ideal effects encountered by this research were 
surmountable.  Solutions to many of the problems was to simply avoid or 
evacuate air intrusion into the system.  Additionally, sufficiently large diameter 
lumens were employed where there was a free surface that would otherwise 
allow any surface tension or capillary effects to occur. Bottom-side die stimulation 
was used versus top-side for liquid media compatibility.  Fluid transfer into the 
bottom-side cavity was eliminated by micro-positioning 30-gauge needles to pre-
wet the cavity.  Glass cylinders or tubing was utilized to eliminate outgassing.  
Where outgassing could elsewhere occur, material choices were made to 
minimize the impact or was otherwise allowed to stabilize prior to use. 
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CHAPTER FIVE  
CONCLUSIONS AND RECOMMENDATIONS 
In summary, chronic intracranial hypertension, or hydrocephalus, is a debilitating 
condition that affects millions of people.  Prior to shunt treatments in the 1950’s 
hydrocephalus was typically fatal.  Shunts are life saving devices, but have yet to 
be perfected and, as a result, have about a 50% failure rate by their second year 
of implant.  The typical onset of symptoms for hydrocephalus often begins with a 
headache which can shortly thereafter lead to fatal consequences without 
intervention.  The same is true for a failed shunt and nearly all shunted patients 
undergo a surgical revision for replacement by year 10.  Such headaches are not 
only associated with escalating hypertension, however.  Shunts often under- or 
over-drain CSF, particularly under siphoning conditions, which also presents with 
a headache.  Therefore, headaches for hydrocephalus patients are not always 
indicative of a forthcoming life-threatening emergency.  The conundrum is, short 
of invasive procedures, there are currently no accurate means of measuring ICP 
to understand if a shunt has failed, needs adjustment, or if a headache is 
otherwise benign.  Patients, well aware of shunt failure rates and the ensuing 
consequences frequently undergo ionizing imaging diagnostics.  Such imaging is 
often inconclusive, and patients next undergo invasive techniques for assessing 
or revising their shunt.  Billions of dollars are spent each year on the diagnostics 
and treatments of hydrocephalus when many of these costly procedures could be 
reduced with non-invasive and non-ionizing diagnostics for measuring ICP.  
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Similar to arterial blood pressure diagnostics, which are easily and reliably 
performed in a patient’s home, a non-invasive means of quantitative ICP 
measurement would allow early alerts of escalating ICP and further enable 
hydrocephalus shunt valve optimization.  Clearly, the need exists for such a 
diagnostic device and researchers have cited a long-standing need for telemetric 
ICP technology. 
As found from a survey of the literature, drift in pressure measurement accuracy 
has been, and remains, the inhibiting factor to enabling a viable long-term 
implantable ICP device.  Offset error has been identified to frequently occur from 
a change in ex-vivo to in-vivo temperatures upon implant.  Gain error, however, 
has been found multifactorial, yet with thermally induced packaging stress as the 
predominant factor.  Other degradations include bonding damage, oxidation 
growth, and the deterioration of an integrated circuit’s photo-resistive layer.  A 
recent study concluded that sensor drift was largely unpredictable, making 
deterministic compensation techniques challenging.  Evaluations conducted over 
several years of this research found even the most sophisticated driftless 
commercial devices drift in excess of 20% and with large unpredictable shifts.  
The research herein has resulted in a new, novel, and patented diagnostic 
approach to mitigating both offset and gain drift in low-pressure liquid-media 
sensing.  The approach exploits the effect of gravitational siphoning in shunt 
systems to provide a means for gain and offset calibration.  By utilizing two 
independent, yet matched, silicon sensor dies, known pressure changes in one 
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bio-compartment can be used for calibrating sensor measurements in another, 
such as the brain.  The work herein included construction of the new device and 
the evaluation of crucial performance aspects necessary for long-term ICP 
measurement. 
Several custom dual biopressure sensors were constructed and tested over the 
course of this research.  As outlined in Chapter Three’s Requirements, a number 
of research objectives were established for evaluating the new sensor.  Table 13 
provides the keyed objectives which were traced throughout Chapter Four’s 
Results and Discussion.   
O1.1 – 1.3 relate to the overall requirement that the implantable biopressure 
sensor provide biocompatible interfaces.  The results from Chapter Four 
examined the materials of the new sensor as well as materials that may be used 
in conjunction with the sensor dies.  Overall, the materials were referenced to 
prior studies showing strong biocompatibility and hermeticity suitable for 
sterilization and implant in humans. 
O2.1 relates to the requirement that the overall transponder be geometrically 
compatible as a cranial implant.  A very standard device geometry, currently in 
clinical use, was selected to compare its volume with that of the sensor’s overall 
transponder components.  Chapter Four tabulated the results and demonstrated 
fulfillment of the objective. 
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Table 13 – Research Objective Fulfillment 
Research Objectives Fulfillment 
O1.1 Justification of sensor to present a bottom-side 
bulk micromachined monocrystalline die 
surface for the pressure diaphragm to meet 
biocompatibility.  Die must be capable of 
bonding to suitably hermetic biocompatible 
materials.  Sensor must withstand sterilization 
method(s). 
✓ 
O1.2 Device to be capable of sustaining a 
compatible wash and autoclaving, ethylene 
oxide, or gamma radiation sterilization without 
damage. 
✓ 
O1.3 Surfaces to be capable of hermeticity to meet 
the intended service life of the implant. ✓ 
O2.1 The sensor's transponder components must be 
capable of being contained within a typical CSF 
reservoir's volume (34 mm diameter and 
7.2mm height) for suitable implantation below 
the scalp, yet above the skull, with pressure 
communication through a cranial burr hole. 
✓ 
2,960 < 3,464 mm3 
Limit 
O3.1 Sensor must provide a pressure range from -
500 mm H2O to +500 mm H2O. ✓ 
O3.2 Sensor must provide a 10 mm H2O resolution, 
or less, up to 200 mm H2O and within a 10% 
maximum beyond. ✓ 3.4 mm H2O  
O3.3 Sensor must provide a maximum accuracy (or 
trueness) of ±5 mm H2O. ✓ 
3.73 mm H2O  
O3.4 Sensor must provide a maximum precision of 
±5 mm H2O. ✓ 
1.16 mm H2O 
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Table 13 (continued) 
Research Objectives Fulfillment 
O3.5 The sensor must overall provide a combined 
maximum accuracy (incl. precision) of ±10 mm 
H2O.over a ±200 mm H2O range and 10% 
maximum beyond. 
✓ 
4.89 mm H2O  
O4.1 Buffered sensor output must be capable of 
providing a signal within a 0 - 3.3 volt range for 
interfacing to the Texas Instruments CC2541 
ADC and Bluetooth LE system-on-chip. 
✓ 
0 - 3.08V 
O4.2 The estimated power consumption of the 
sensor's transponder must be less than that 
which can be transcutaneously transmitted 
safely per IEEE Standard for Safety Levels with 
Respect to Human Exposure to Radio 
Frequency Electromagnetic Fields, C95.1.  
✓ 
0.146 < 3.648 W Limit 
O4.3 The sensor must be capable of gain and offset 
calibration to meet the specified accuracy. ✓ 
O5.1 Expected drift over the device's intended 
service life must be less than ±50 mm H2O. ✓ 
Correctable to within 
2.75 mm H2O 
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O3.1 – 3.5 stem from the requirement that the sensor provide clinically 
acceptable ICP resolution and accuracy.  Each objective was justified within the 
context of clinical literature for providing diagnostics to hydrocephalus patients.  
The pressure range, resolution, and accuracy were all demonstrated by the new 
custom device to fulfill the objectives. 
Objectives O4.1 – 4.3 relate specifically to the sensor’s ability to support non-
invasive calibration and readout.  The sensor and front-end electronics were 
shown compatible with a prevailing wireless Bluetooth LE system-on-chip (SoC).  
Additionally, the power consumption of the sensors and transponder components 
were shown to be within safe limits for transcutaneous powering.  Finally, both 
objectives O4.3 and O5.1 were satisfied with data demonstrating the new 
device’s capability for self-calibration to mitigate large gain and offset drifts to 
within 3 mm H2O. 
In conclusion, a survey of the literature and of the most recent technology 
indicates that measurement drift over time is the limiting factor to enabling long-
term implantable ICP monitoring.  Research herein pursued a means of reducing 
and overcoming such drift.  A new novel patented device and calibration method 
thereof utilizing matched-dies with dual references to mitigate drift was 
developed and evaluated.  The device and method demonstrated the ability to 
negate large shifts in gain and offset in the laboratory to within a few millimeters 
of water pressure, showing promise for in-vivo application.  Future research will 
seek to replicate the sensor system and performance in-vivo in an animal model. 
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